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INTRODUCTION 
Tuberculosis is a chronic debilitating infectious disease which has a 
high morbidity and mortality. Center for disease control and prevention says 
that ‟about one-third of the world’s population is infected with tuberculosis’’. 
In 2015, 10. 4 million people around the world were found to be sick with 
tuberculosis and there were 1. 8 million tuberculosis related death due to 
unawareness regarding treatment, 50-65% of the patients died within a year 
(Fauci A, Kasper D, Braunwald E 2008)2 In India, nearly 1. 98 million new 
cases reported every year which constitute nearly 20% of the global total 
tuberculosis disease burden. RNTCP in India is declared as the second largest 
in the world (Moharani et al)19. Non adherence is one of the main drawbacks in 
the management of this disease because tuberculosis patients expected to have 
adherence greater than 90% for cure (Harries A, Maher D, Graham S (2004)3,4.  
WHO definitions and reporting framework for tuberculosis -2013 
revision says that, ‟a tuberculosis patient whose treatment was interrupted for 2 
consecutive months or more is known as lost to follow up and treatment after 
default is currently termed as treatment after lost to follow up’’. Factors like 
forgetfulness, being in the continuation phase of the treatment, feeling better 
with the drugs, co-morbid HIV infections, poor understanding about the illness, 
concluding that tuberculosis is a mere physical illness or incurable one were 
found to be the reasons for non-adherence in studies conducted in developing 
countries (Sardar P et al, Akilew Avoke Adane et al, Sudhir et al)5, 6, 20 Other 
factors like type of housing in which people reside, overcrowding, 
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homelessness are also been proved as cause for non adherence as per Garfein et 
al 201021  
Studies have shown high prevalence of depression, generalized anxiety 
disorders, adjustment disorders in patients with tuberculosis (Westaway et al 
1992, Aghanwa et al 1998)1, 7 
Low self esteem, fear of spreading the illness to others, helplessness 
brought out by incapacitation due to chronic illness, and social  
stigma associated with the illness, are all causes that one can postulate for 
depression and anxiety (Argiro et al 2013)17. After knowing the diagnosis of 
tuberculosis, patients tend to have mixed feelings of loneliness, depression, 
suicidal thoughts, fear, apathy, surprise and acceptation due to the stigma 
(Argiro et al 2013)17 Prevalence of depression was 27% according to previous 
studies9 (Baba et al 1985) and Indian studies (Natani et al)10have shown 
prevalence is 49%  
Alcoholism and other drug addiction also play a role in poor drug 
adherence (Rose N et al 1991)8 Alcohol can directly cause a person to default 
from treatment and a delay in the diagnosis of tuberculosis was also associated 
with alcoholism (Brian Lacky et al)11,19 Previous studies show that heavy 
drinkers also have serious forms of tuberculosis, high chances of default, 
relapse and continue to be infectious to others, at high risk for premature death 
posing serious public health concerns (Jianzhao H et al 2011, Finlay A et al 
2002, Vree M et al 2007)12,13,14 Unsuccessful outcome like relapse and default 
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are high among patients who consumed alcohol during the course of treatment 
as the bacteria is mainly destroyed by alveolar macrophages and alcohol will 
promote intracellular survival of mycobacterium by suppressing phagocytosis 
and impairs the immune system responses against tuberculosis18. The need for 
a pre-treatment psychological assessment for screening of alcohol use disorders 
have been highlighted by Karthikeyan et al18 study 2014. Detecting alcohol use 
disorders like abuse and dependence helps in early intervention effects to 
prevent the adverse impacts of consumption.19 
Previous studies have described the personality of tuberculosis patients 
as ‟childish, self-centered, irritable, dissatisfied with life” (Jelliffe et al 1919)15 
Many patients who suddenly discontinue the treatment in a sanatorium and go 
for default were mainly found to have chronic alcoholism (Ashmore et al 
1943)16 Patients found to be mostly associated with poor drug adherence and 
default mainly had neurotic traits, were submissive, emotional labile and over 
protective and behavioral modification by psychotherapy for neurotic traits 
proved to be effective in prevention of default as per studies done by Sudhir 
choudary et al20 
As per Bergman, Haley, and Small22 (2011) mental variables or health 
beliefs such as attitude, values and knowledge about health and health service 
also decide drug adherence. Psychological distress is defined as a ‟state of 
mind where the emotional suffering is associated with depression and anxiety” 
(Drapeau et al., 2011; Vidyulatha Peddireddy, 2016)24,28 High levels of 
psychological stress, adverse life events were associated with tuberculosis 
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(Geldenhuys et al., 2011)25 which produced a negative impact on the treatment 
adherence. Studies also insist the need for psychological interventions in 
individuals with chronic illness as they may indulge in risk taking behavior 
which adversely affects the treatment outcome. Patients with psychological 
distress tend to die before 25yrs when compared with general population 
(NASMHPD, 2006)26 and have very poorer quality of life (Veggi et al., 
2004)27. Psychological distress in tuberculosis patients and the need for 
psychological intervention is still under-studied among Indian population as 
per Vidyulatha Pedireddy, 201628         
Social stigma which is defined as, ‟ an undesirable or discrediting 
attribute that an individual possesses, thus reducing that individual’s status in 
the eyes of society place a vital role in the management of chronic illness like 
tuberculosis as well as psychiatric illness” (Gofmann et al 1963)23 In India, 
stigma was more prevalent among women (Dhingra and Khan, 2010)29. In a 
study that recruited TB patients from South India, it was observed that distress 
and anxiety was observed in about 50% of the study subjects when disclosed 
about the diagnosis and about 9% of them attempted suicide (Rajeswari et al., 
2005)30Among Indian population, studies say that psychological reaction was 
severe, when patients were informed about the diagnosis of TB and the main 
worries were mainly about the deadliness of the disease, treatment options, 
embarrassment, social stigma and the feeling that fate was not kind to them 
(Thakker et al., 2014) 31Psychological intervention improved the patients’ 
treatment compliance, outcome and levels of CD4+T lymphocytes (Wei et al 
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2016)32 But the studies highlighting the role of psychological factors including 
psychiatric illness is very meager in Indian population28 
In Tamil Nadu, the default rate was 20% which was more than twice as 
that of the national average and the main causes were stated as alcoholism, 
warranting the need for motivation strategies to enhance drug adherence 
(Jaggarajamma et al)33 Failure rates in Tamil Nadu was found to be 13. 2% 
where north of India reported failure rates of 7% (Pauline et all201134, Singla et 
al 2009)35 
Prior studies show that in Tamil Nadu, depression was nearly 42% 
among tuberculosis patients and being old, married, educated, female and 
higher income group were found to have lower incidence of depression 
(Francis et al 2017)36 About 29% of tuberculosis patients abused alcohol and 
among them nearly 52% had a AUDIT score>8 which actually signifies 
hazardous, harmful and dependent drinking (Beena Thomas et al)37 
   Heavy drinkers face the dual stigma of alcoholism and tuberculosis 
and among tuberculosis defaulter patients 47% were heavy drinkers and odds 
ratio was 3. 8% for heavy drinkers when compared with other causes of default 
(Jabuboviak et al, Jaggarajamma et al, De Albuquerque et al)38,33,39 
   The fear of the adverse effects of TB drugs and alcohol, the fear of the 
reduction in the therapeutic effect of the drugs when alcohol is consumed and 
the fears of being reprimanded by health providers when they report to the 
clinic with an odor of alcohol are the adverse factors associated with the drug 
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adherence which leads to default (Beena Thomas et al)37 and this study 
conducted in Tamil Nadu also highlight the need for the involvement of family 
members in intervention programs.  
Studies recognize the need to screen TB patients for alcohol use and 
encourage abstinence, targets risky alcohol users, including those in alcohol 
treatment programs to enhance TB screening as per Government of India 
RNTCP training module 201440 
      Studies identifying prevalence of psychiatric illness, alcoholism and 
personality factors is very meager. India has a high burden of tuberculosis, 
along with psychiatric illness faces heavy stigma and has got grave effect on 
outcome of both illness. This study is an effort in that direction.  
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REVIEW OF LITERATURE 
LOST TO FOLLOW UP 
Tuberculosis patients lost to follow-up (LTFU) are defined as 
“Tuberculosis patients who did not start treatment or whose treatment was 
interrupted for two consecutive months or more” and were previously called 
defaulters41. LTFU patients are more likely to redevelop infectious active TB, 
and are found at a higher risk of developing MDR-Tb (Caminero et al 2010)42 
Lost to follow up occurred more often in the continuation phase (58. 8%) than 
in the intensive phase of treatment (34. 2%) (Jessica et al)43 
People living with TB and mental illness are at greater risk of poor 
health-seeking behaviour, and poor medication adherence with consequent 
adverse treatment outcomes including morbidity, mortality, drug-resistance and 
ongoing disease (Sweetland et al 2014)44 Prevalence of psychiatric co-
morbidity was found to be nearly 70% as per Doherty et al 201345 and was 
associated with high levels of social disability, social stigma, poor social 
support and physiological disturbances (Aydin et al46 and Pachi et al17) 
Tuberculosis and psychiatric illness share common risk factors like poverty, 
substance abuse and homelessness (Doherty et al 2013)45 
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PSYCHIATRIC DISORDERS AND TUBERCULOSIS: 
Mental disorders make a substantial independent contribution to the 
burden of disease worldwide (Baxter et al)47 Common mental disorders 
(CMDs) are characterized by a broad range of depressive, anxiety or 
somatoform symptoms, including irritability, insomnia, nervousness, fatigue 
and feelings of uselessness (Fonseca et al)48 In developing countries, the 
prevalence of Common mental disorders varies between 20%–30% (Patel et al 
2003)49Psychiatric illness have a chronic and disabling nature, cause intense 
subjective suffering and affect individuals’ abilities to care for their own health 
(Fonseca et al48, Veggi et al27)  
‟Reduction in vital energy” and “depressive thoughts” reflect individual 
stressors; stress can mediate the relationship between psychosocial problems 
and physical illness, as stress has an effect on the bacterial load in the lungs and 
the immune defense system (Stein et al50, Schneiderman et al)51 
     Few studies which tried to establish a relationship between 
psychiatric illness and tuberculosis have highlighted the effects of stress on 
immune functioning and the progression from infection to disease and also that 
the diagnosis of tuberculosis increases risk of mental Illness (Doherty et al45, 
Balaji et al52, Bender et al53) The association between psychiatric illness and 
tuberculosis contributes to the inadequate adherence to the proposed  
treatments and aggravates the clinical description of both diseases  
(Pachi et al17, Prince et al54) 
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Tuberculosis can be wrongly diagnosed as a common mental disorder in 
mental health clinics and might raise the public health costs unnecessarily 
(Pachi et al17, Deribew et al55) Hence the need for inclusion of mental health 
program integrated within tuberculosis control program suggested by Gleide 
Sandos et al 201456 
RELATIONSHIP BETWEEN PSYCHIATRIC ILLNESS AND 
TUBERCULOSIS: 
    McQuistion et al 199757 has found that 30% of patients with 
depressive illness and 14% with psychotic illness have a positive PPD (Purified 
Protein Derivative) results. Lopez et al58 gives 19% prevelance for PPD 
admissions to a psychiatric unit. Saez et all59 (1975) gives 36. 7% of men in a 
homeless hostel with mental illness showed a positive PPD results.  
Psychiatric patients also have risk factors like poor nutrition, smoking, 
diabetes mellitus which results in the progression from latent to active 
tuberculosis as per Doherty et al45 (2013) 
Chronic medical illness are commonly associated with psychiatric 
illness like depression (Moffic et al)60 and Aghanwa et al7 says that rate is 
twice than in orthopedic patients but less than chronic respiratory illness as per 
Moussas et all61 
Non-compliance with the treatment resulting in MDR-tuberculosis was 
found to be associated with psychotic disorders and substance abuse as per 
LaRaja et al62 (1997) Number of strategies which have been suggested to 
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overcome this problem of non-compliance including residential treatment, and 
even isolation of patients with mental illness and co-morbid tuberculosis, 
resulted in increase the individual’s stress levels (Westaway et al 1992)1 
Among opioid-dependent patients, when direct observation treatment 
was combined with methadone maintenance therapy, outcome was good as per 
Bhatki et al63Chronic respiratory illness was associated with increased risk of 
suicide (Horton et al 1992)64 Wagenlaher et al65 (2006) described a case of 
psychosis secondary to milliary tuberculosis with significant involvement of 
the urinary tract at initial presentation.  
Panic disorder was found to be secondary to tuberculous meningitis, and 
a case of frontal tuberculoma presenting as a postnatal depression has been 
reported (Chand et al 199666, Stavrou et al 200267) 
ADVERSE EFFECTS OF ANTI-TUBERCULOSIS TREATMENT: 
Psychiatric adverse effects in the treatment of tuberculosis has been 
reported widely and is associated with poorer outcome and increased mortality 
rates (Baghaei et al 2011)68 
Isoniazid has been reported in terms of psychiatric adverse effects with a 
prevalence rate of 1. 9/10069 patients and the first mention of this in the 
literature is in 1956 (Cohn et al 1957)70 Prodrome of psychosis featured by 
anxiety, emotional lability and facial twitching has been reported with 
Isoniazid (Wasik et al 1970)71 
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MECHANISM /THEORIES 
ISONIAZID: 
Psychosis due to Isoniazid is due to the effect of depletion of pyridoxine 
(vitaminB6), which is the mechanism whereby neuropathy occurs. Although 
pyridoxine supplementation is recommended in patients taking isoniazid who 
are at risk of neuropathy due to underlying medical conditions, such as 
diabetes, uraemia, alcoholism and HIV infection, it is not effective in the 
treatment of psychosis secondary to isoniazid (Chan et al 1999)72 
Another mechanism by which Isoniazid induces psychotic symptoms is 
its ability to act as a monoamine-oxidase inhibitor (MAOI), with alteration of 
the metabolism of catecholamines, which could theoretically induce a manic 
psychosis in patients with a predisposition to mood-instability (Alao AO et al 
1998)73 
Isoniazid was the first of the MAOIs to be considered for the treatment 
of mental disorders in the 1950s, when it was found to be associated with 
improvements in the mental states of patients with psychiatric disorders, both 
in those with and those without psychosis, with some patients noted to be 
“inappropriately happy” (Rosenfeld et al 1955)74 
Isoniazid may interact with antidepressant medications, and this is based 
on its action as a weak MAOI (Robinson et al 1968)75 Sullivan et al76 described 
41 patients presenting to a New York city emergency department with 
isoniazid toxicity, 27 of whom reported attempting suicide by this means. One 
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study compared suicides in patients with tuberculosis with those with other 
cardio-respiratory illnesses, found excess in number of suicides in the 
tuberculosis group, which is attributed to anti-tuberculous agents (Farberow et 
al 1966)77 
CYCLOSERINE 
It is a cell wall inhibitor acting as a D-Alanine substrate penetrating the 
blood-brain barrier associated with 20-33% increase of psychiatric illness. 
(Helmy. B 1970)78 Mechanism of action is, diminished central nervous system 
(CNS) production of -aminobutyric acid (GABA) caused by inhibition of 
glutamic decarboxylase (Berning et al 1999)85. Emotionally unstable 
personality, history of alcoholism and female sex are predisposing factors for 
the development of cycloserine induced psychosis. (Bankier RG 1965)79 
Cycloserine is contraindicated in patients with seizure disorder and psychiatric 
illness with agitation (Kass et al 2010)80 
RIFAMPICIN 
Rifampicin is a potent cytochrome P 450 enzyme inducer and results in 
reduction in the serum levels of drugs like sertraline (Markowitz et al 2000)81 
which produces discontinuation syndrome and also reduce methadone levels in 
opiate dependent individuals warranting increase in dose of methadone during 
co-treatment with methadone (Backmund et al 2000)82 
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LINEZOLID 
     Linezolid causes serotonin syndrome in patients receiving multiple 
anti-depressants and the incidence was proved to be 35% (Lawrence et al 
2006)84. The average time of onset was 9. 5 days from the day of 
commencement of treatment and the average duration was 2. 7 days (Morales 
et al 2005)83 
OTHER DRUGS 
Ethambutol associated with mania and psychosis (Pickles et al86 1996, 
Hsu et al87 1999) Fluoroquinolones have been implicated in rare occurrences of 
psychosis (Mulhall et al 1995)88 and depression (Feinberg et al 1995)89 
SUICIDE IN TUBERCULOSIS PATIENTS 
  Karl peltzer et al90 2013, states the predictors for suicidal ideation in a 
tuberculosis patient as being female, being a TB retreatment patient, 
psychological distress. Risk factors for a suicidal attempt are being a TB  
re-treatment patient, had decided to stop TB treatment before, PTSD 
symptoms, harmful alcohol use, having one or two other chronic illnesses and 
having ever been diagnosed with an Sexually transmitted infection93.  
Scales used in Karl Peltzer et al study are PC-PTSD and K-10. 
Components of PC-PTSD are re-experiencing, avoidance, hyperarousal and 
numbing. The Kessler Psychological Distress Scale K10 shows symptom 
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pertaining to non-specific depression, anxiety and substance abuse, but does 
not measure suicidality or psychoses 
Suicidal ideation was found to be 9% and attempt was found to be 3. 1% 
(Karl peltzer et al)90 Factors like neuropsychiatric morbidity, alcohol and drug 
abuse, behavioral disorders found to increase the risk for suicide (Starace 
1995)91 
Suicide was very high in cases of Multiple drug resistant tuberculosis 
who were on Category 2 drugs and had co-morbid illnesses like deafness, lung 
abscess, Arthralgia, HIV/AIDS, extra-pulmonary spread, moderate/severe TB 
(Lasebikan)92 and medical comorbidity is found to be a independent risk factor 
for suicide (Conwell et al)97 
Atilola et al93 found that certain groups like Yoruba were highly 
susceptible for suicide as death was preferred to shame, dishonor and indignity 
associated with chronic respiratory illness like tuberculosis and its due to social 
cognition.  
Alcohol precipitates suicide by means of its serotonin lowering 
mechanism (Kamali et al 2001)94 disinhibitory effects, as a result of 
intoxication or addiction (Meninger 1938)95and due to the pain (Fishbain 
1999)96 
Depression is found to be a strongest predictor for suicide (Guruje et al 
2007)98 Causes of depression in a tuberculosis patients are release of pro 
inflammatory mediators like interleukin-6 (Kiecolt et al)99 which can be the 
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result of a chronic condition and biologically results in a depressive illness, 
hypoxia associated with tuberculosis also results in anxiety and depression 
(Fenty et al )100, other causes are loss of weight, fatiguability and psychological 
losses (Mikkelson et al 2004)101 
Mann et al study102 in Nigeria recommends that to understand the nature 
of suicide and its high, certain programs like “Gatekeeper training program” to 
be included in tuberculosis control program which is currently not available in 
many countries.  
Ige OM et al103 states the prevelance of depression as 13. 4% and 
psychosis as 2. 7% in care givers of tuberculosis and necessitate the need for 
tuberculosis control program for care givers.  
Presenting complaints of depression varies with the general population 
as somatic complaint is the common presenting complaint along with 
fatiguability, anhedonia, insomnia (Nutt et al104 2001, Cavanaugh et al105 1998, 
Patel106 2001) 
DEPRESSION 
  Depression is the most common psychiatric diagnosis in tuberculosis 
which is associated with a high chance of morbidity and mortality (Prince M et 
al54 2007, Duarte et al107 2009) as well as poor drug adherence as depressive 
patients fail to seek medical attention for their physical complaints also due to 
the lethargy and fatiguability associated with depression.  
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Balkissou et al109 gives the prevelance of depression in tuberculosis 
patients as 30. 9% Female gender, BMI<18. 5kg/metre2, retreatment for PTB 
due to previous default or relapse, a family history of psychiatric illness, stigma 
associated with the illness, discontinuing anti-tuberculosis treatment and co-
morbid illness like HIV has high chances of depression (Jules Kehbila et al109 ), 
Cardiovascular illness, chronic obstructive pulmonary disease, Diabetes 
mellitus and previous history of depressive episodes are the other risk factors 
associated with depression. Loss of libido, physiological role of adrenal gland 
in mediating effects on stressful life events impedes the course of tuberculosis 
and Adrenal- cortical activity plays a vital role in the treatment resistance to 
tuberculosis (Supriya adipudi et al)113 
   Features associated with depression are worthlessness, hospitalization, 
social stigmatization and loss of income which lead to self-depreciation, 
conscious and unconscious fear of chronicity and death (Tandon et al110,  
Morris et al111).  
Cough is found to be an independent risk factor associated with 
depression as the patient and care givers perceive the illness as a worsening one 
and also the treatment ineffective which increases the patients’s burden. Cough 
produce impairment in work place, school, affects sleep and social life. Patients 
with chronic cough must be screened for depression and they benefit from 
depression treatment (French CL et al 1998)112 
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Stressful situation precipitated by the illness results in fuctional 
impairment, social and respiratory isolation, fear of spreading the illness to 
others, lowering of self esteem, incapacitation due to the chronicity of the 
illness (Kelly et al114, Argiro et al17) Depressive individuals are prone for 
substance abuse and tend to have unprotected sexual intercourse which results 
in sexually transmitted illness like HIV-AIDS (Prince M et al)54 
Depression among tuberculosis patients is very common than the 
general population after a mean duration of 6. 5 years and has got an adverse 
effect over the quality of patient-physician relationship and so they tend to 
make frequent visits to physician for vague somatic complaints but delay the 
visits in times of important medical complications (Yen et al115, Katon et al116, 
Prince M et al54) 
Stigma is a significant contributor and study by Ayla et all117            
shows that nearly 50% of the patients who got discharged couldn’t re-unite 
with their respective families due to the hostile nature and stigma of the family 
members.  
Study by Muhammad Anwar et al118 compares the prevelance of 
depression among tuberculosis with that of other chronic medical illnesses and 
states that among 80% of the depressive patients, 45. 8% were suffering from 
moderate depression and 37. 8% were severely depressed when compared with 
56. 1% of depression in patients receiving hemodialysis, 88. 2% of depression 
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in patients with chronic liver disease, 51. 9% of the patients with 
dermatological illness who were diagnosed with depression.  
Olusoji et al119 states that nearly 22% of the patients were severely 
depressed and they never seeked for any medical attention for their depressive 
symptoms and 13. 4% of the primary care givers were severely depressed 
secondary to the chronicity of the illness, sacrifices made by them and as they 
spend entire day in care giving which poses a serious public health threat and 
extended family system was found to be a protection factor against depression.  
  Study by Kunal Kumar et al120 says that before the diagnosing 
tuberculosis, patients present with symptoms of apprehension about the future, 
irritability, insomnia, restlessness, reduced appetite and interaction with others 
due to the fear of the illness and uncertainty about the diagnosis. After 
confirmation of diagnosis, patients tend to have a sense of relief immediately 
but slowly become depressed, irritable, anxious, and exhibit episodes of 
aggression towards family members due to excessive worry about the nature of 
illness and its complications.  
    Adolescents were found to be much bothered about their body image 
and functioning, tend to abuse alcohol and substance more, had poor drug 
compliance, reduced appetite, more non-co-operation and hostility towards the 
staff and the physician and suicide was low when compared to that of older 
adults120 
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MANAGEMENT 
Reduction of stigma, counseling by health care providers regarding drug 
adherence, maintanence of self care and diet, avoidance of opportunistic 
infections, found to be a vital move in reducing the psychiatric disturbance 
among tuberculosis patients (Amare deribew et al)55 
Quality of life was a useful tool in assessing the impact of common 
mental disorders in tuberculosis patients and co-morbid HIV infection was 
associated with reduced scores in the quality of life measures55 Stangl et al121 
study (2007) in Uganda found that in tuberculosis patients with co-morbid 
HIV, 12 months course of Anti-retroviral treatment produced a significant 
improvement in mental status and quality of life of the patient.  
Regarding the pharmacological management, antidepressant like 
Citalopram were found to be metabolized by CYP2C19 and CYP3A4 both  
are inhibited by Isoniazid, which results in increased serum concentrations  
of citalopram, hence not preferred in depression patients on isoniazid.  
(Adam Trenton et al)122 
 Doherty et al45 says that Isoniazid and Linezolid itelf has got Mono 
Amine Oxidase Inhibitor property and acts as an antidepressant though MAOI 
are currently the third choice of drug for depression after SSRIs and Tricyclic 
antidepressants.  
WHO guidelines131 suggest that patients on anti-tuberculous drugs 
presenting with depression must be assessed for co-existing substance abuse, 
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individual or group counselling must be initiated in those patients and 
regarding pharmacological management, drugs like amitryptaline or fluoxetine 
can be prescribed and SSRIs and tricyclic antidepressants can be prescribed to 
the same individual but should not be given to those patients receiving 
linezolid. Lowering the dose of cycloserine and ethionamide to 500mg/day or 
stopping the suspected drug without compromising the regimen can be 
initiated, depressive symptoms fluctuate during therapy and might revert back 
to normal once the illness is treated successfully, suicidal ideations must be 
assessed once the diagnosis of depression is made, cycloserine should not be 
started in case of previous history of depression.  
  In case of suicidal ideation, ptient must be hospitalized and put under 
24 hour surveillance, cycloserine must be stopped, anti depressant treatment 
must be initiated, lower the dose of ethionamide to 500 mg/day, hospitalization 
must be continued till the risk of suicide passes off and if no improvement, 
ethionamide should also be stopped131 
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PSYCHOSIS 
ISONIAZID 
Psychosis in a tuberculosis patient is mostly secondary to drugs like 
Isoniazid and Ethambutol where Isoniazid causes depletion of Vitamin B6 
(Pyridoxine ) which interferes with tryptophan metabolism and  
reduces pyridoxal 5 phosphate which again reduces Gamma Amino Butyric 
Acid and other neuro transmitters resulting in neurological side effects. 
(Girling D. J 1984)123 Other precipitating factors for the occurrence of a 
psychotic illness are advancing age, Diabetes Mellitus, liver insufficiency, 
alcoholism (Prasad et al)124 
Clinical features of Isoniazid induced psychosis were excessive adamant 
speech, grandiosity, aimless wandering, irritability, aggression, emotional 
instability, delusions, sleep disturbance which started after initiation of 
treatment and most of the patients lacked prior episodes of psychiatric illnesses 
and symptoms subsided spontaneously without any treatment as soon as the 
drug was discontinued. (Jackson125, Agarwala et all126, Bedi 127)  
Siddarth Arya et al130 reported psychosis within 3 days of starting 
Isoniazid along with clinical features like loosening of association, echolalia 
and previous neurological insult as a risk factor. 
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ETHAMBUTOL 
Another common drug used in the treatment of tuberculosis causing 
neurological side effects like retrobulbar neuritis and occurrence of psychosis is 
very rare124Hsu et al87 decribes the clinical features of ethambutol induced 
psychosis as dizziness, disorientation, auditory and visual hallucinations within 
7 days of the intake of the drug.  
TUBERCULOUS MENINGITIS 
Irrelevant talk, irritability, disorganized behavior, reduced oral intake 
and constipation, defective social interaction, dull and withdrawn behavior, 
sleep disturbances, on and off headache were the presenting features in a case 
of tuberculous meningitis which presented as acute psychosis (Atmesh 
Kumar)128 Rahim129 describes stupor, social isolation, mutism and akinesia in a 
patient with tuberculous meningitis.  
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MANAGEMENT 
Prasad et al124 describes that there are no specific treatments for 
Isoniazid induced psychosis as symptoms reduce after removing the offending 
drug and Pyridoxine which is used in the treatment of Isoniazid induced 
neurological manifestations failed to show effectiveness in the case of a 
psychosis.  
Rahim129 states that psychosis secondary to tuberculous meningitis 
improved with anti-tuberculous drugs and steroids 
WHO Guidelines131 suggest that in patients with psychosis, suspected 
drugs like cycloserine and isoniazid should be stopped atleast for 2-4 weeks 
while psychotic symptoms are under control, patients at risk to themselves and 
to others must be hospitalized, in cases of moderate- severe psychotic features 
first generation drugs like Haloperidol must be started, cycloserine dose must 
be reduced to 500mg/day and pyridoxine dose must be increased to 200mg/day, 
if the patient is completely off cycloserine, anti psychotics can be stopped and 
if cycloserine is continued or restarted, low dose anti psychotics to be 
continued.  
Previous history of psychiatric illness, though not a contraindication to 
cycloserine therapy increases the future risk of psychotic episode and reduced 
renal parameters increases the serum concentration of cycloserine and results in 
psychosis.  
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ROLE OF ALCOHOL 
Karthikeyan Duraisamy et al18 found that among default patients, 
alcohol consumption was found to have a hazard ratio of 4. 3 but it was not 
found to be an independent risk factor for default and death during treatment, 
patients with alcohol consumption were found to miss more than 7 intensive 
phase doses and on average about 18 when compared with patients who do not 
drink alcohol.  
Study by Beena Thomas et al37 found that many patients stated their 
alcohol consumption was the main reason behind their diagnosis of 
tuberculosis as loss of appetite set up an immunologically suppressed condition 
making them vulnerable to acquire tuberculosis and few respondents also said 
that consuming alcohol during tuberculosis treatment adversely affect the 
outcome, few said that they couldnot quit alcohol during the treatment course 
and if they had a drink, they would fear about the drug and alcohol interactions 
and would avoid visiting TB clinic due to the fear of being reprimanded by the 
physicians.  
    Alcohol consumption more than 40gms/day was associated with 
increased chances of smear positive cavitary pattern, longer duration for smear 
conversion and increased chances of drug toxicities (Brown et al132, Lonnroth 
K, Williams BG et al133, Francisco et al134, Fiske et al135) Drug resistant strains 
of Mycobacterium is also common among alcoholics (Romanus et al)142 
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  Samai Laprawat et al136 gives the following three different patterns of 
drinking among patients on tuberculosis treatment 
1) Few patients tend to stop alcohol during the beginning of the treatment 
but after 3-4 months succumb back to drinking once their general 
condition improves.  
2) One set of patients completely quit their alcohol consumption after the 
therapy which significantly improved their relationship with their family 
members 
3) Third group which continued the alcohol consumption during the course 
of treatment 
       Certain factors for the decline in alcohol consumption highlighted by 
Samai Laprawat et al136 are intervention strategies attempted by the health care 
providers, adverse effects of taking alcohol along with anti tuberculosis drugs 
and change in the natural changes in the pattern of drinking during the course 
of the treatment  
       Daxini Arvind et al137 study on 150 treatment defaulters and 150 
treatment completed control groups showed that odds ratio for alcoholism 
between cases and controls were 4.75 which proves that patients consuming 
alcohol during the course of treatment have 375% more chances of defaulting 
when compared with that of patients who do not drink.  
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       People using alcohol forget to take anti-tuberculosis drugs leading to 
default and continued alcoholism compromise liver function tests which 
increase the hepatotoxic side effects of the drugs (Nirmalya Roy et al)139 
         Daily consumption of alcohol at the start of the treatment was associated 
with high chances of lost to follow up and patients with alcoholism tend to 
move out of their residence often, give false addresses, reside in slum areas, 
difficult to locate, abandon treatment more often (Ibrahim et al 2012)140 
             Venkateswarlu et al141 says that nearly 25% of the patients who 
defaulted from treatment were consuming alcohol and more than half of the 
defaulters and treatment failures spent money on alcohol. 
         Defaulters tend to remain infectious and poses a threat to their families 
as well the community because the mycobacterium strain become resistant to 
first line anti-tuberculous drugs (Farah et al 2005)143 
          Under the influence of alcohol, patients exhibit altered behavior and 
have more side effects leading to default and relapse (Sonam lepcha et al)144 
Alcoholism alters the metabolism of anti tuberculosis drug like Isoniazid, 
lowers the serum concentration of the drug, shortens the half life, reduced 
absorption of the drug resulting in treatment failure and poor outcome 
(Koriakin et al)145 
        Hector147 in his post mortem studies found that alcoholism was a 
common antecedent factor in individuals without a genetic predisposition 
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towards tubercle bacilli and also that broncho pneumonic consolidation was the 
most common type of tuberculosis in patients with alcoholism 
ALCOHOL IN GRAMS AND ITS EFFECT ON TUBERCULOSIS: 
      Alcohol consumption was responsible for 10% incident cases and deaths 
reported (Jurgem Rehm, Samokhvalov et al)146 Sameer Imtiaz148 meta-analyses 
study gives the risk of tuberculosis associated with alcoholism as 35% when 
compared with that of the population which doesnot drink. Past alcohol use 
was not significantly associated with tuberculosis when compared with that of 
absenteeism. In this study, increase in risk based on grams of ethanol was given 
as 1. 57 at 25 grams of ethanol, 2. 46 at 50 grams, 3. 85 at 75grams, 6. 03 at 
100grams. Alcohol consumption more than 60grams/day was associated with 
68% increased risk of tuberculosis when compared with that of no alcohol. 
Tuberculosis attributable to alcohol consumption was found to increase by 50% 
in many countries.  
        Higher consumption results in higher attributable tuberculosis disease 
burden (Rehm J, Anderson P et al 2013)149Men who consume more than 38 
grams of ethanol were not found to be at increased risk for tuberculosis but the 
risk started to increase by four fold thereafter but women who drink were not 
found to be at increased risk for tuberculosis. (Francisco et al)134 
      Molecular epidemiological studies implicate the spread of tuberculosis 
is facilitated by alcohol consumption in social situations like bars, prison, 
social institutions. (Diel et al150, Zolnir et al151, Cassen et al152) 
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       After controlling the factors like age, sex and smoking on alcoholism, 
Kolappan et al156 found that patients who consume alcohol were found to be 
associated with 1. 5 times higher risk than persons who do not consume 
alcohol.  
     Relative risk of 2 for heavy alcohol consuming patients was reported by 
Buskin et al157 Coetzee et al158 found the relationship between problem 
alcoholism in household, overcrowding and its relation with the spread of 
tuberculosis. Coetzee gives the definition of a household with alcohol problem 
as “a household in which atleast one member reports alcohol as a problem” 
There was a significant association between alcohol problems in the household 
and tuberculosis risk which was independent of the employment status and the 
result was confirmed by many other tuberculosis research workers.  
        Maria de fathima et al159 study says that people who drink everyday or 
who find difficulty in cutting down their daily alcohol were at increased risk 
for treatment failure in tuberculosis as well as have combined negative 
outcome which is nothing but the increased chances of developing tuberculosis 
and poorer response to treatment.  
       Baski et al160 study define heavy drinkers as‟ those who drink average 
of 3 or more drinks daily or more than average of 5 every time he drinks”, 
heavy drinkers were twice the risk of developing tuberculosis when compared 
with non-heavy drinkers as they tend to lack homes, never attended 
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rehabilitation treatments, had poor nutritional status and ciliary function to get 
rid of tubercle bacilli 
       Vidal et al161 found that in the prospective study of 1235 patients, 
hepatotoxicity was found to be present in 36% of the patients with risk factors 
like alcoholism and chronic alcohol induced liver disease when compared with 
the 13% of the patients without any of these risk factors.  
      Carola et al162 found that in patients who developed serious liver damage 
with elevated serum transaminases >150 units/litre on treatment with Isoniazid 
and Rifampicin were mostly men with chronic history of alcoholism.  
       Alcohol as a risk factor is confirmed by Crampin et al161 but this finding 
was found only among ex-drinkers who gave up alcohol after the diagnosis of 
tuberculosis. Alcohol consumption during the course of treatment make them 
nutrition deficient resulting in nausea and vomiting, also as the general 
condition improves with tuberculosis medications, patients resume back to their 
previous drinking pattern which also results in non-adherence. (Aurora 
Heemanshu181)  
      Respondents in Donald Skinner et al166 study in South Africa say that 
quitting alcohol during the course of treatment segregate them from their peer 
groups and social circles and once they get better, they wish to resume back to 
their social groups. 
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MANAGEMENT OF TUBERCULOSIS WITH ALCOHOLISM 
         Beena Thomas et al37 postulate the following framework adopted from 
Ecological system model by Bronfenbrunner (1979) which includes the 
following: 
‟Micro system-which includes the closest relatives and peer groups 
having bi-directional influence which is both away and towards the alcohol 
habit of the patient 
Meso system-connects micro and health environment 
Macro system-being isolated and labeled in the society, stigma attached 
to excessive and hazardous drinking. 
Chrono system-which determines the duration of time on having an 
influence over the perception of his own drinking pattern exhibiting a positive 
influence on drug adherence” 
        Respondents of Beena Thomas et al37 study also expressed the need for 
awareness about alcohol with pamplets, audio visual tapes and also that 
intervention programs have to be integrated with TB programs, they also 
preferred individual counseling to that of a group counseling and highlighted 
the need to involve their family members in those programs which increased 
their drug adherence. Motivated patients pointed their willingness for de-
addiction treatment, family members opined that such intervention programs 
are likely to improve quality of life of the patient as well as other members.  
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       John R Edsall138 et al opines that daily regimen of Isoniazid and 
Rifampicin for a duration of 6 months will be effective in alcoholic patients 
who tend to have poor adherence, in view of high failure rates in this 
combination, additional 6 months course of less toxic combination of drugs like 
isoniazid and ethambutol to be started which accounts for a total duration of 
12-24 months of treatment. 
        For co-morbid Alcohol Use Disorders in tuberculosis patients, Jurgen 
Rehm et al146 suggest that strict taxes must be made on the sale of alcoholic 
beverages and availability must be reduced through coherent liquor outlet 
policy.  
        Lonnroth, Migliori et al153 put forth that elimination of alcoholism in 
low incidence settings is essential for reducing the incidence of tuberculosis 
because when tuberculosis incidence reduces, it becomes more and more 
confined among high risk group like heavy alcohol consumers and those with 
alcohol related problems and health care workers must be trained in addressing 
this issue.  
       WHO End TB strategy 2015 states that, ‟ reducing alcohol and alcohol 
related disorders is essential to cut down the social determinants of health”. 
This strategy imply the need for targeting the social determinants which cut 
down the transmission chains which in turn reduces tuberculosis disease 
burden. (Lonnroth Jeramillo et al155, Lonnroth Castro et al156)WHO End Tb 
strategy164 2006 recommends the health care providers involved in tuberculosis 
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treatment to include associations involved in the treatment of alcoholism, 
opioid abuse, psychological clinics and also religious bodies to improve the 
drug adherence of the patient.  
      Naltrexone and behavioral counseling integrated into the tuberculosis 
treatment improved adherence in one randomized control trial by Shin et al165 
McDonald et al167 study found that Directly Observed Treatment Shortcourse 
therapy on Out Patient basis was found to be effective in chronic alcohol 
dependent individuals in whom ambulatory treatment which was not given 
under any supervision got failed.  
     Imtiaz et al study168 proposes two different approaches for treatment of 
substance use disorders and tuberculosis. In first approach screening, diagnosis 
of pattern of alcohol use disorder and plan for effective pharmacology must be 
implied by health care professionals involved in tuberculosis treatment. In 
second one, screening of high risk individuals like alcohol users especially 
vulnerable groups like homeless individuals, people released from prison must 
be screened for tuberculosis.  
ROLE OF PERSONALITY FACTORS 
       Study conducted in 214 patients by Sudhir et al20 concluded that  
“53. 2% were neurotic, 26. 2% introverts, 18. 2% were extroverts and 2. 2% 
had other personality traits” Among defaulters, majority had neurotic 
personality traits, very few introverts were present and none were extroverts 
(Vernier et al)169 Most of the defaulters were found to be less involved in the 
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environment. Neurotic personality default more and retrieve less when 
compared with other personality traits. Behavioral modification through 
effective psychotherapy, repeated counseling increases adherence and improves 
treatment completion rate when compared with single session (Charles et al)170  
          Study by Vinogardov et al171 states that negative attitude towards 
treatment, impairment in social adaptation, neglect of the generally accepted 
behavior, schizoid personality traits. Individual response to disease detection 
were determined by a number of symptom complexes like hypochondriasis (13. 
6%) and being paranoid (9. 1%). These traits adversely affected affected the 
treatment outcome and a long term management on conservative grounds again 
worsened the hysterical and schizoid personality traits.  
     Shirley Brinkerhoff in his book on Personality disorders172 states that 
Anti tuberculosis drug Iproniazid which found to improve depression due to its 
monoamine oxidase enzyme inhibiting action was also found to be effective in 
avoidant personality disorders as well as in social phobia but requires cautious 
usage due to its dietary and drug interactions and is not widely preferred now.  
Case control study by Janmeja et al173 showed that the group with pre 
treatment psychological assessment and psychotherapy showed better drug 
adherence and cure rates when compared with control group without 
psychological intervention and suggests the role of psychotherapy in reducing 
the rates of relapse, default.  
 34 
       Bansal et al study174 (2010) conducted in 214 out-patients registered in 
DOTS centre Kanpur assessed personality factors among tuberculosis patients 
using 16-Personality Questionnaire states that 54. 1% were anxious personality, 
26% were introverts, 15. 8% extroverts and 4. 1% had other personality traits.  
      Locus of control categorized as internal, powerful others, luck or chance 
as a predictor of personality factors by Obadiora, A. H175 states that powerful 
others is a strong predictor of drug adherence. Among these three, powerful 
others involving the role of family members and health care workers who 
provided the directed observed treatment was considered as the psychological 
predictor of personality based on which treatment packages directed towards 
improving adherence can be planned.  
      Immerman et al176 showed that among 232 patients, 64% of the patients 
were found to have neurotic traits and anti-tuberculous treatment failed to 
control the symptoms in nearly 51% of the patients necessitating the inclusion 
of psychotherapy in the treatment.  
PREVELANCE AS PER PREVIOUS STUDIES 
       Prospective study by Alok Bharadwaj et all177 defined non-compliance 
as “The extent to which a person's behavior (in terms of taking medications, 
following diets, or executing lifestyle changes) coincides with medical or 
health advice” This study conducted in 44 tuberculosis patients in KLES 
hospital and research centre found that nearly 13 members were alcoholic 
(33%) and 26 of the patients were non alcoholic (66%)  
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       Kelly Dooley et al study178 conducted in 291 patients who have come 
for re-treaatment from a period of one year from June 2008-2009 states that 
only 2 members were found to have alcoholism (3%)This study states this 
finding as a limitation as alcoholism is meager in Morocco and so the role of 
alcoholism in drug adherence couldn’t be concluded with this study and the 
results of this study couldnot be generalised to the population.  
      In the study conducted by Ana Paula et all179 to estimate the Health 
Related Quality of Life, Anxiety and Depression in hospitalized patients with 
tuberculosis, 119 patients who met the inclusion criteria were enrolled among 
them, 86 participated in the study, Anxiety and depression were assessed with 
the help of Hospital Anxiety And Depression rating scale. Results were that 
more than one-third of the patients had a diagnosis of anxiety (38. 4%) and 
depression (34. 4%)  
      Case control study conducted in Nairobi by Muture et al180 between 
January 2006 and March 2008 involving 120 cases and 154 controls shows that 
default rates were higher during the initial 2 months of intensive phase of 
treatment and also that many factors were individually associated with high 
default rates. Alcohol consumption leading to forgetting of drug intake was 
found in 9 patients amounting to 7. 5% and psychiatric conditions were found 
in 3 individuals, which amounts to 2. 5% 
      Alcohol abuse, defined as “recurring use of alcoholic drinks despite the 
negative consequences’’ was found to serve as a predictive factor for default 
 36 
with a odds ratio of 4. 97. This study also states that in Nairobi, cheap local 
brews are found to be sold in very congested places and are hot spots of 
spreading tuberculosis to others and higher risk of further defaulting. 
Alcoholism also results in liver damage and causes drug interactions with anti-
tuberculosis drugs leading to greater liver damage.  
      Since alcohol abuse is found to be an independent predictor for default 
in this study, need to find targeted interventions which improves adherence in 
tuberculosis patients with co-morbid alcohol abuse is recommended in this 
study.  
      Multi-stratified study conducted by Aurora Heemanshu et al in 204 adult 
tuberculosis patients enrolled in category-1 treatment in New Delhi found that 
44 members (21. 6%) had history of alcoholism. Patients with alcohol 
consumption had 2. 4 times increased risk of treatment default when compared 
with patients without alcohol consumption.  
       Aurora Heemanshu et al181 also states that alcohol consumption during 
the course of treatment was associated with greater default and combined with 
poor nutrition status resulted in adverse effects like nausea and vomiting. This 
also highlights the need for continuous and effective health education, repeated 
motivation and counseling.  
      Study conducted by Yadav et al182 in Agra in 272 tuberculosis patients 
used Wing’s screening Present State Examination (PSE) and diagnostic 
guidelines as per ICD -10 to screen psychiatric illness found that 29. 4% 
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suffered from a psychiatric co-morbidity, 19. 4% had depression and 6. 6% had 
anxiety. 36% of the patients treated in the Out Patient set up had a co-morbid 
psychiatric disorder.  
     Mathai et al183 conducted a study in 70 tuberculosis In-patients and 70 
controls who had non-tuberculous bronchiectasis and this study population was 
followed for a duration of over 6 months in order to avoid reactions secondary 
to the effects of anti-tuberculosis drugs and also to rule out CNS causes if any. 
After the initial clinical evaluation, diagnosis was confirmed in accordance 
with ICD-9. 28. 87% of psychiatric illness was found, among which 15. 7% 
constituted depression, 7% had anxiety and 3% had alcohol dependence 
syndrome.  
       Bhatia et al184 conducted a study in 50 Out-Patients attending a Tb 
hospital in Delhi and used EPQ-R (Eysenck’s Personality Questionaire-
Revised) to assess neurotic traits and Dysfunctional Analysis Questionaire 
(DAQ)Nearly 78% of the patients scored significantly on neuroticism scales 
and the scores correlated with the subscales of Dysfunctional Assessment 
Questionnaire and had greater psychosocial dysfunctioning.  
     Chandrasekhar et al185 conducted a study in 100 tuberculosis patients in 
Bangalore using MINI-International Neuro Psychiatry Interview scale found 
46% of the patients had psychiatric illness among which 36% had depression, 
24% had anxiety and 16% had co-morbid illness of both anxiety and 
depression. Depression was found in patients belonging to lower socio-
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economic status, staying for longer duration as In-Patients, on non-RNTCP 
group of drugs. Anxiety was found to be predominant in patients with less 
education and patients who had tuberculosis associated with complications.  
      Gelmanowa et al186 conducted a study in 207 patients enrolled in DOTS 
programme found that 8. 8% of the patients defaulted from the study and 
substance abuse was found to be an independent predictor for default and 
alcohol was found to be associated with an odds ratio of 4. 38 and 6. 25 was the 
odds for reported alcohol use during treatment. Alcohol abuse was associated 
with an odds ratio of 15. 57 for default.  
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AIMS AND OBJECTIVES 
AIMS 
       To study the prevalence of psychiatric co-morbidity, alcohol abuse and 
personality factors in tuberculosis default patients.  
PRIMARY OBJECTIVE 
       To study the prevalence of psychiatric illness, alcohol abuse, personality 
factors among tuberculosis defaulter patients 
       To study the role of these factors in Anti tuberculosis drug 
discontinuation 
SECONDARY OBJECTIVE 
       To study the relationship between psychiatric illness, alcohol abuse, 
personality factors and tuberculosis default 
       To study the relationship between personality factors and alcohol abuse 
       To study the relationship between demographic profile and tuberculosis 
default 
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HYPOTHESIS 
NULL HYPOTHESIS 
      There is no significant association between tuberculosis default and 
psychiatric illness. 
      There is no significant association between tuberculosis default and 
alcohol abuse. 
      There is no significant association between tuberculosis default and 
personality factors. 
      There is no significant association between various personality factors 
and alcohol use. 
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MATERIALS AND METHODS 
SETTING 
       The study was conducted in Government Thiruvoteeswarar tuberculosis 
hospital Otteri Chennai, a tertiary care centre for tuberculosis in Tamil Nadu. 
The necessary prior permission for conduct of the study was obtained from 
Director Tuberculosis hospital and Institutional Ethics Committee, Madras 
Medical College, Chennai 
STUDY POPULATION 
       Tuberculosis patients who have been diagnosed as default or lost to 
follow up admitted as In-patients in Government Thiruvotteswarar tuberculosis 
hospital Otteri Chennai were selected for the study. Patients who have 
defaulted treatment for atleast 2 months were enrolled in the study.  
SAMPLE SIZE: 
      A total of 110 sample size of tuberculosis patients who defaulted 
treatment were included in the study.  
SAMPLE SIZE CALCULATION: 
      For this cross –sectional study, sample size calculation was done in 
accordance with the Muture et al study180 which shows a 7. 5% prevalence of 
alcohol use and 2. 5% psychiatric illness as a reason for default.  
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     Formula used in cross –sectional studies to calculate sample size is  
Sample size=Z2×p×q÷d2 
Here Z-1. 96 
p-0. 075 
q-0. 93 
d-0. 05 
We arrive at a sample size of 96 in accordance with this study and so a 
sample size of 110 being enrolled in our study.  
PERIOD OF STUDY: 
      The study was conducted for a duration of 4 months from March 2017-
August 2017 
SAMPLING METHOD: 
      Non probability sampling cross-sectional 
RESEARCH DESIGN: 
CROSS-SECTIONAL STUDY: 
      110 patients admitted as in-patients in Government Thiruvoteeswarar 
tuberculosis hospital fulfilling the criteria for lost to follow up or default were 
chosen up for the study.  
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INCLUSION CRITERIA: 
1)  Patients diagnosed as Tuberculosis default or lost to follow up admitted 
as in-patients 
2) Age 20-60 yrs 
3) Patients who are able to given written consent and wish to participate in 
the study 
EXCLUSION CRITERIA 
1) Subjects who have other neurological illness 
2) Subjects with age less than 20 and more than 60 who have other medical 
illness 
3) Subjects with medical illness other than tuberculosis default like 
tuberculosis relapse or sequelae 
4) Subjects who do not wish to participate in the study 
OPERATIONAL DESIGN 
After obtaining the written informed consent from the participants as 
required by the Institutional ethical committee  
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INSTRUMENTS USED: 
  1) Socio-economic profile 
  2) SCID 
  3) AUDIT 
  4) 5 factor questionnaire 
5) HAMD 
6) YMRS 
7)  PDSS 
SEMI STRUCTURED PROFORMA: 
    It was used to collect subject’s socio-demographic details like name, 
age,  sex, education, occupation, marital status, address, unemployment in 
terms of months, diagnosis of tuberculosis in months, past history of 
tuberculosis, adherence in months during the past episodes, income according 
to modified Kuppuswamy scale. 
SCALES USED: 
ALCOHOL USE DISORDER IDENTIFICATION TEST: 
    This Alcohol use disorder identification test (AUDIT)187 questionnaire 
helps to identify persons with excessive drinking and recognizes hazardous and 
harmful patterns of alcohol consumption. This provides a base for treatment 
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and for planning individualized deaddiction programmes. It has got 10 
questions. Ist to 3rd question are on alcohol consumption; 4th to 6th are on 
alcohol drinking behaviour and dependence;7th to 10th questions are on the 
consequences or problems related to drinking.  
1st to 8th question – scored as 0, 1, 2, 3, 4 on five –point scale.  
9&10th question –scored as 0, 2, 4 on a three –point scale.  
Maximum score-40 
YOUNG MANIA RATING SCALE: 
This Young Mania Rating scale (YMRS)188 is used to assess the severity 
of the manic symptoms during the episode and during the recovery phase. It 
consist of 11 items scored on a likert scale 0 to 8 for four items, 0 to 4 for 7 
items. Reliability is good based on inter-rater reliability studies.  
HAMILTON’S RATING SCALE: 
Max Hamilton first introduced this Hamilton’s rating scale [HAM-D or 
HDRS]189 in 1960. It is accepted widely and used to assess the severity of the 
depression and helps as a follow up guide to assess the treatment response in 
the recovery phase.  
It has high inter-rater reliability and validity. Many version of HDRS are 
available. In HAM-D 21 item version only 17 items were given scores and 
others are taken up for clinical information like hypersomnia, increased 
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appetite and concentration and indecision. It takes about 20 minutes to 
administer.  
Eight items scored from 0 to 4 and other 9 items are scored from 0 to 2. 
[0= not present;4=very severe].  
 
SCID (STRUCTURED CLINICAL INTERVIEW FOR DSM 
DISORDERS) 
     SCID module was used to screen psychiatric illness and patients who 
fulfill the criteria were assessed with scales and scoring was made.  
5 FACTOR MODEL RATING FORM: 
     Patient self-rated questionnaire where the patient must rate themselves 
on a 1-5 scale on the personality traits, 30 in number. Scoring from 1-5 
    1-Extremely low 
    2-Low 
    3-Neither high or low 
    4-High 
    5-Extremely high  
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PANIC DISORDER SEVERITY SCALE: 
      Clinician rated scale to assess the severity of panic disorder. 7 item 
questionnaire to rate the overall severity of individuals already diagnosed as 
panic disorder. It assess symptoms over the past one month. It provides 
information about the frequency of panic attacks, panic foussed anticipatory 
anxiety, avoidance of agarophobic situations, avoidance of panic related 
physical sensations, impaired social and occupational functioning (shear et 
al)191 
SCORING: 
  0-none 
  4-Extreme 
 Total score- 0-28 
 Cut off-8 
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RESULTS AND OBSERVATIONS 
SOCIO-DEMOGRAPHIC PROFILE 
SEX 
     
    Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid F 6 5. 5 5. 5 5. 5 
  M 104 94. 5 94. 5 100. 0 
  Total 109 100. 0 100. 0   
 
 
F-Frequency and P-Percentage in all the graphs 
Males constituted 94. 5% and females constituted 5. 5% of the total 
sample collected.  
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EDUCATION: 
 
In this sample 23 members (21%) were illiterates, 11 members (10%) 
studied upto 4th class followed by 10 members (9. 2%) studied upto 9th std 
whereas only 6members (5. 5%) entered college  
 
INCOME: 
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  Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid <2 48 44. 0 44. 0 44. 0 
>2 53 48. 6 48. 6 92. 7 
0 8 7. 3 7. 3 100. 0 
Total 109 100. 0 100. 0   
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In this sample, 53% had income above 2000 rupees and 48% found to 
have income less than 2000 rupees.  
PLACE: 
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    In this sample, 6 members (5. 5%) were from Villivakkam and Otteri,  
5 members were from Washermenpet (4. 6%), 4 members (3. 7%) were from 
Kolathur and Egmore.  
MARITAL STATUS: 
  
  Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid M 90 82. 6 82. 6 82. 6 
M, S 1 . 9 . 9 83. 5 
UM 16 14. 7 14. 7 98. 2 
W 2 1. 8 1. 8 100. 0 
Total 109 100. 0 100. 0   
 
In this sample, 90 members (82. 6%) were married, 16 members were 
unmarried (14. 7%), 2 were widower (1. 8%), 1 was married and separated  
(0. 9%) 
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RELIGION: 
  Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid C 12 11. 0 11. 0 11. 0 
H 92 84. 4 84. 4 95. 4 
     
M 5 4. 6 4. 6 100. 0 
Total 109 100. 0 100. 0   
 
In this study, 92 members (84. 4%) were following Hinduism,  
12 members (11%) were following Christianity, and 5 members were following 
Islam (4. 6). 
CO-MORBID ILLNESS: 
     91 members (83. 5%) had no comorbid illness, 7 had Diabetes Mellitus  
(6. 4%), Diabetes Mellitus and Systemic Hypertension was found in 3 members 
(2. 8%), Decompensated Liver Disease was found in 2 members (1. 8%) 
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:  
FAMILY HISTORY OF PSYCHIATRIC ILLNESS: 
 
In this sample, 62 members (56. 9%) had no family history of 
psychiatric illness, 21 members reported alcohol dependence pattern in their 
father (14. 3%), 3 reported alcohol dependence in their elder brother (2. 8%)6 
members reported alcohol dependence in their elder brother and father (5. 5%) 
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OTHER SUBSTANCE USE: 
 
Apart from alcohol, beedi smoking was reported by 11 (10. 1%), beedi 
and cigarette smoking reported by 16 (14. 7%), Hans usage by 4 members  
(3. 7%) 
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SUMMARY OF DEMOGRAPHIC DATA RESULTS 
 
   Regarding age, mean age was found to be 45 years (Range 37-53) 
Median value for number of months not occupied is 7 months (Range 3-12), 
Months before which tuberculosis was diagnosed had a median value of  
6 months (Range 4-6 months), ATT adherence in months has a median value of 
2 months (Range 1-3), Last drink in months value was found to have a median 
value 2 months (Range between 15 days-3 months)Alcohol Dependence in 
years found to have a median value off 8 years which fell midway between 3-
15 years. 
ALCOHOL DEPENDENCE: 
  Frequency Percent 
N 30 27. 5 
Y 79 72. 5 
79 members (72. 5%) reported alcohol dependence syndrome in this 
sample. AUDIT score Above 8 was found in this sample 
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7 members (6. 4%) had score of 18, 9 had score 34 (8. 3%), 11 had a 
score of 40 (10. 1%), 14 had a score of 38 (12. 8%), 15 had a score of 36  
(13. 8%) 
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In this sample, 64 members (58. 7%) stated alcohol consumption as the 
reason for quitting anti tuberculosis medicines, Others were nausea by 9 
members (8. 3%), 5 stated the reason as work (4. 6%), 4 (3. 7%) said that they 
felt good after the intensive phase and so only they quit the drug.  
COMPARISON BETWEEN ALCOHOL DEPENDENCE AND OTHER 
PARAMETERS: 
ALCOHOL AND INCOME 
  
INCOME/MONTH 
<2 >2 0 
 ADS N Count 10 15 5 
% 
within 
ADS 
33. 3% 50. 0% 16. 
7% 
Y Count 38 38 3 
% 
within 
ADS 
48. 1% 48. 1% 3. 
8% 
Total Count 48 53 8 
% 
within 
ADS 
44. 0% 48. 6% 7. 
3% 
 
  Value df 
Asymp. Sig.  
(2-sided) 
Pearson Chi-Square 5. 999a 2 . 050 
 
48 members with alcohol dependence had income less than 2000 (44%) 
and with a significant p value of 0. 05 
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ALCOHOL AND PSYCHIATRIC ILLNESS: 
Among 4 members who had psychiatric illness, 2 had alcohol 
dependence syndrome. p value is not significant in this group. 
  
Psychiatricillness 
Yes No 
ADS N Count 2 28 
% within 
ADS 
6. 7% 93. 3% 
Y Count 2 77 
% within 
ADS 
2. 5% 97. 5% 
Total Count 4 105 
% within 
ADS 
3. 7% 96. 3% 
  
 
  Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. 
(2-
sided) 
Exact 
Sig. 
(1-
sided) 
Pearson Chi-Square 1. 052a 1 . 305     
Continuity 
Correctionb 
. 207 1 . 649     
Likelihood Ratio . 942 1 . 332     
Fisher's Exact Test       . 303 . 303 
N of Valid Cases 109         
 
P value was found to be 0. 303 according to Fisher’s exact test. 4 
members only included in this so Fishers exact is used because for any value 
less than 5, this statistical method is a valid one.  
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ALCOHOL DEPENDENCE AND FAMILY HISTORY OF 
PSYCHIATRIC ILLNESS: 
  
Family history 
psychiatricilness 
Total Yes No 
ADS N Count 8 20 28 
% within 
ADS 
28. 6% 71. 4% 100. 
0% 
Y Count 36 42 78 
% within 
ADS 
46. 2% 53. 8% 100. 
0% 
Total Count 44 62 106 
% within 
ADS 
41. 5% 58. 5% 100. 
0% 
 
 
In Fisher’s exact test, sigma 1 tailed showed value of 0. 08 and sigma  
2 tailed showed value of 0. 122 which is not statistically significant. So alcohol 
dependence group did not have any significant association with family history 
of psychiatric illness.  
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ALCOHOL DEPENDENCE AND PRIOR TUBERCULOSIS EPISODE: 
    
  
Prior_TB 
Total Yes No 
ADS N Count 13 17 30 
% within ADS 43. 3% 56. 7% 100. 
0% 
Y Count 26 53 79 
% within ADS 32. 9% 67. 1% 100. 
0% 
Total Count 39 70 109 
% within ADS 35. 8% 64. 2% 100. 
0% 
 
 
 
p value according to Pearson is 0. 311 which is not statistically 
significant and so no positive association between alcohol dependence 
syndrome and prior episode of tuberculosis.  
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ADS N Mean P value 
Standard 
Deviation 
NOT OCCUPIED 
MONTHS 
Yes 79 5. 595 . 438 3. 0740 
TT ADHERENCE 
MONTHS 
Yes 79 2. 1485 . 385 1. 43204 
AUDIT                    Yes 79 32. 05 . 000 7. 490 
LAST DRINK 
MONTHS 
Yes 79 2. 4259 . 000 6. 66458 
ADS DURATION 
YEARS 
Yes 79 13. 766 . 000 9. 9350 
PRIOR TB IN 
YEARS 
Yes 79 . 949 . 559 2. 0857 
PRIOR TB ATT 
ADHERENCE IN 
MONTHS 
Yes 79 1. 082 . 244 1. 7384 
QUIT BEFORE Yes 79 . 190 0. 009 1. 6876 
   
   When alcohol dependence was compared with months of 
unemployment, tuberculosis treatment adherence in months, prior episode of 
tuberculosis, prior treatment adherence in months, significant p value was not 
found. With AUDIT score a mean value of 32+/-SD was found and p value was 
significant (<0. 05), last drink in months was found to have a mean of 2. 
4259+/- SD and a p value of 0. 00 was found, years of alcohol usage was found 
to be 13. 766+/- SD and a p value was 0. 000.  
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ALCOHOL DEPENDENCE VS PERSONALITY FACTORS 
PERSONALITY FACTORS WHICH DOESNOT HAVE A 
CORRELATION WITH ALCOHOL DEPENDENCE (p>0. 05): 
PERSONALITY FACTORS P VALUE 
Competence 0. 183 
Altruism 1. 000 
Self discipline 0. 477 
Activity 1. 000 
Gregariousness 0. 477 
Excitement 1. 000 
Anxiousness 0. 663 
Impulsivity 0. 068 
Assertiveness 1. 000 
Feelings 0. 303 
Depressiveness 0. 491 
Self-consciousness 0. 560 
Modesty 0. 682 
Aesthetics 0. 477 
Trust 0. 477 
Straightforwardness 1. 000 
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ALCOHOL VS ANGRY HOSTILITY: 
  
Angry hostility 
Total No Yes 
ADS No Count 22 8 30 
% 
within 
ADS 
73. 3% 26. 7% 100. 0% 
 
Yes Count 26 53 79 
% 
within 
ADS 
32. 9% 67. 1% 100. 0% 
Total Count 48 61 109 
% 
within 
ADS 
44. 0% 56. 0% 100. 0% 
 
 
p value using pearson chi-square found to be 0. 000 and significant.  
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ALCOHOL DEPENDENCE VS VULNERABILITY: 
      
  
Vulnerability 
Total No Yes 
ADS No Count 25 5 30 
% within 
ADS 
83. 3% 16. 7% 100. 
0% 
 
     Yes Count 42 37 79 
% within 
ADS 
53. 2% 46. 8% 100. 
0% 
Total Count 67 42 109 
% within 
ADS 
61. 5% 38. 5% 100. 
0% 
  
 
Here 2 is the p value according to pearson chi-square test which has a 
value of 0. 004 stating that alcohol dependence has a correlation with 
vulnerability as a personality factor.  
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ALCOHOL VS VALUES 
 (PERMISSIVE, BROAD –MINDED) 
  
VALUES 
Total No Yes 
ADS No Count 25 5 30 
% within 
ADS 
83. 
3% 
16. 7% 100. 0% 
 
Yes Count 77 2 79 
% within 
ADS 
97. 
5% 
2. 5% 100. 0% 
Total Count 102 7 109 
% within 
ADS 
93. 
6% 
6. 4% 100. 0% 
 
 
p value here is 0. 01 and is statistically significant.  
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ALCOHOL AND TENDER MINDEDNESS 
  
Tendermindedness 
Total No Yes 
ADS No Count 24 6 30 
% 
within 
ADS 
80. 0% 20. 0% 100. 
0% 
 
Yes Count 77 2 79 
% 
within 
ADS 
97. 5% 2. 5% 100. 
0% 
Total Count 101 8 109 
% 
within 
ADS 
92. 7% 7. 3% 100. 
0% 
 
 
P value is 0. 002 which is significant for tender mindedness personality 
factor and alcohol dependence.  
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ALCOHOL VS COMPLIANCE (DOCILE, CO-OPERATIVE) 
  
Compliance 
Total No Yes 
ADS No Count 23 7 30 
% within 
ADS 
76. 7% 23. 3% 100. 
0% 
 
Yes Count 77 2 79 
% within 
ADS 
97. 5% 2. 5% 100. 
0% 
Total Count 100 9 109 
% within 
ADS 
91. 7% 8. 3% 100. 
0% 
 
 
In Fisher’s exact, p value is 0. 002 which is statistically significant for 
the compliance factor.  
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ALCOHOL DEPENDENCE VS WARMTH FACTOR 
  
Warmth 
Total No Yes 
ADS No Count 26 4 30 
% within 
ADS 
86. 7% 13. 3% 100. 
0% 
 
Yes Count 76 2 78 
% within 
ADS 
97. 4% 2. 6% 100. 
0% 
Total Count 102 6 108 
% within 
ADS 
94. 4% 5. 6% 100. 
0% 
 
  
p value is significant for warmth factor (0. 04) 
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PSYCHIATRIC ILLNESS AND TUBERCULOSIS 
  Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid   3 2. 8 2. 8 2. 8 
AH 1 . 9 . 9 3. 7 
BPAD-1M, 1D 1 . 9 . 9 4. 6 
DEPRESSION 1 . 9 . 9 5. 5 
N 102 93. 6 93. 6 99. 1 
PANIC 1 . 9 . 9 100. 0 
Total 109 100. 0 100. 0   
 
 In this sample, 4 members were found to have psychiatric illness, 1 was 
found to have Auditory hallucinations secondary to alcohol use, 1 patient had 
BPAD on drugs euthymic with YMRS score-8, 1 was found to have Panic 
disorder symptoms and a score of 8 in Panic Disorder Severity Scale, 1 had 
depression with HAMD scores 12 but was not on any drugs.  
PSYCHIATRIC ILLNESS VS OTHER PARAMETERS 
  
Mean age was found to be 45. 45+/- standard deviation, Months of 
unemployment in this group had a median value 7 (Range3-12), Tuberculosis 
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diagnosed in this group was found to be before 6 months (Range 4-6 months), 
ATT adherence in months found to have median value of 2 months (range 1-3 
months)Last drink in months was found to have a median value 2 months 
(Range 0. 6-3 months)Alcohol duration in years was found to have a median 
value of 8 (Range 3-15 months) 
PSYCHIATRIC ILLNESS VS OTHER GROUPS: 
PSYCHIATRIC 
ILLNESS 
FREQUENCY FISHER’S 
EXACT (p) 
ALCOHOL 
DEPENDENCE 
2 0. 303 
CMI 1 0. 520 
PRIOR 
TUBERCULOSIS 
1 1. 000 
FAMILY 
HISTORY OF 
PSYCHIATRIC 
ILLNESS 
2 1. 000 
 
Among 4 members with psychiatric illness, 2 had alcohol dependence,  
1 had co-morbid medical illness, 1 had prior history of tuberculosis but none 
was statistically significant as per fisher’s exact test.  
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Psychiatricillness  N Mean Std. Deviation P value 
NOT 
OCCUPIED 
MONTHS 
Yes  4 4. 500 3. 8730 0. 303 
      
TB 
DIAGNOSED 
BEFORE 
MONTHS 
Yes  4 6. 750 1. 8930 0. 555 
      
ATT 
ADHERENCE 
MONTHS 
Yes  4 2. 1250 1. 03078 0. 890 
      
AUDIT Yes  4 28. 00 18. 762 0. 574 
      
LAST DRINK 
MONTHS 
Yes  4 1. 5000 1. 73205 0. 553 
      
ADS 
DURATION 
YEARS 
Yes  4 9. 250 8. 2209 0. 761 
      
PRIOR TB IN 
YEARS 
Yes  4 . 750 1. 5000 0. 785 
      
PRIOR TB 
ATT 
ADHERENCE 
IN MONTHS 
Yes  4 1. 000 2. 0000 0. 816 
     .  
      
QUIT 
BEFORE Yes    
  4 0. 000 0. 000 . 605 
 
p value was not found to be statistically significant when compared with 
other groups. 
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PREVELANCE OF PERSONALITY FACTORS: 
  
PERSONALITY 
FACTORS 
FREQUENCY PERCENTAGE 
Anxiousness 19 17. 5 
Angry hostility 61 56 
Impulsivity 59 54. 1 
Vulnerability 42 38. 5 
Assertiveness 16 14. 7 
Feelings 4 3. 7 
Values 7 6. 4 
Depressiveness 11 10. 1 
Self consciousness 3 2. 8 
Modesty 8 7. 3 
Tender Mindedness 8 7. 3 
Compliance 9 8. 3 
Warmth 6 6. 4 
Aesthetics 2 1. 8 
Trust 2 1. 8 
Straightforwardness 4 3. 7 
Excitement seeking 2 1. 8 
Gregariousness 2 1. 8 
Activity 1 0. 9 
Self-discipline 2 1. 8 
Altruism 1 0. 9 
Competence 3 2. 7 
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In this study, 56% reported to have angry hostility, 54. 1% found to have 
Impulsivity, 38. 5% had vulnerability, 17. 5% members reported to have 
anxiousness, 14. 7% found to have assertiveness and 10. 1%reported that they 
had depressiveness, least reported factors were activity which included energy, 
active. It was reported by 0. 9% of the members only.  
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DISCUSSION 
    Aim of this study was to study the prevelance of psychiatric illness, 
alcohol abuse and personality factors among tuberculosis default patients and 
to study the role of these factors in anti tuberculosis drug discontinuation.  
RESULTS IN DEMOGRAPHIC PROFILE 
        In this 110 sample, regarding sex, majority were males (94. 5%) The 
lesser percentage in females is an indirect indicator of stigma which in 
accordance with the previous study by Dhingra et al29 which shows that stigma 
is high among females which leads to poor drug adherence. Nearly 53% had 
their income more than 2000 rupees. In terms of education, 21% were illiterates 
and only 5. 5% were found to have completed college degree. Nearly 5. 5% of 
the patients reported from the areas Villivakkam and Otteri where tuberculosis 
hospital was located and this high default in the same area is again an indirect 
indicator of poor knowledge regarding drug intake and stigma associated with 
the illness which prevents the patients from adherence.  
     About 90% of the population enrolled were married which indicates a 
good social support, also majority belonged to Hinduism (92%)Co morbid 
illnesses were not found in 90% of the population and this might again explain 
the reason for not seeking medical attention. 6. 4% reported to have Diabetes 
Mellitus which suppress the immune system further leading to high chances of 
relapse and treatment failure followed by Systemic Hypertension (2. 8%) and 
only 2 had Decompensated Liver Disease.  
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    In this sample, 14. 3% had a family history of Alcohol dependence 
syndrome in their father followed by 2. 4% alcohol dependence in their elder 
brother explaining a genetic vulnerability for substance dependence which 
further complicates treatment adherence. Regarding co-morbid substance use, 
beedi smoking was found in 10. 1% and both beedi and cigarette smoking was 
found in 14. 7% of the sample.  
    Mean age was found to be 45 years. Number of months not occupied 
was found to have a median value of 7 months indicating social and functional 
impairment. Tuberculosis diagnosed in months was found to have a median 
value of 6 months and this minimizes the recall bias regarding discontinuation 
of the drug. Anti tuberculosis drug adherence was found to have median value 
of 2 months which is again in accordance with the previous studies which 
proves that patients tend to discontinue anti-tuberculosis drugs soon after the 
intensive phase and this is in accordance with a previous study by Jessica et al43 
which states that defaulters were found to be more during the initial 
continuation phase as they tend to feel better with drugs soon after they 
complete the intensive phase. This again confirms the findings by Beena 
Thomas et al137 which says that after starting to consume alcohol, due to fear of 
re-visiting the health care professionals, patients tend to discontinue the 
medications. Last drink in this sample was found to be 2 months back denoting 
a highly prevelant dependence pattern and Alcohol dependence syndrome in 
years was found to have median value of 8 years in this sample and this group 
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exhibited pattern of daily consumption of alcohol which as per Fathima et al159 
has a very poor drug adherence and adverse outcome.  
ALCOHOL DEPENDENCE SYNDROME AND OTHER PARAMETERS  
79 members (72. 5%) reported alcohol dependence syndrome in this 
sample and had AUDIT score above 8. This particular percentage is very high 
when compared with the previous studies like Jakuboviak et al38 which showed 
47% and Patel et al 49 study which showed a 20-30% prevalence of alcohol 
dependence syndrome among tuberculosis patients in developing countries. 59 
members had score more than 30 necessitating the need for intervention in this 
group as highlighted by Shin et al165 which put forth the role of both 
pharmacological management like naltrexone as well as behavior modification 
like counseling to increase the motivation of the patients to improve adherence.  
     64 members stated that their alcohol habit was the reason for them to 
discontinue tuberculosis drugs and the result in this study is very high when 
compared with the Muture et al180 study which was chosen for sample 
calculation which quoted only 7. 5% of alcohol dependence syndrome as a 
reason for default.  
    Among the 79 members with alcohol dependence, 48 had income less 
than 2000 rupees with a significant p value which indicates an association 
between alcoholism and lack of employment and poor financial status and this 
confirms the results of Garfein et al21 which put forth overcrowding and 
homelessness results in very high chances of default and relapse rates.  
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   In this study, significant association could not been established when 
alcohol dependence syndrome was compared with parameters like family 
history of psychiatric illness, co-morbid psychiatric illness, prior attack of 
tuberculosis, drug adherence during prior attack of tuberculosis and this finding 
is a deviation from the previous studies like 
Karthikeyan Duraisamy et al18 which states that among defaulters, those 
with alcohol consumption was found to miss more than 7 intensive phase doses 
and on average about 18 when compared with patients who do not drink 
alcohol.  
     Alcohol dependence syndrome was found to have a positive association 
with AUDIT score and mean was found to be 32 which shows more than a 
mere dependence pattern and this is in accordance with Baski et al160 study 
which states that persons who had 3 more drinks daily were heavy drinkers and 
were twice at risk of developing tuberculosis than non-heavy drinkers. This 
result also proves the validity of AUDIT scale which gives a cut off for score 
more than 8 and necessitates the need for intervention in this sample, and it has 
got a mean value of 32. This is again in accordance with the previous studies 
like Imtiaz et al168 which also highlights the need to find out the alcohol use 
pattern based on which management can be planned.  
    Alcohol dependence had a positive correlation with the last drink which 
has a value of 2 months in this study which indicates that many had their last 
drink within past 2 months when they were in treatment. Samai Laprawat et 
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al136 says that patients who stop alcohol during treatment succumb back within 
3-4 months once their general condition improves and the same finding is 
replicated in this study also because at the end of intensive phase of treatment 
many feel that their physical condition has improved and succumb to their 
drinking habits and another pattern of alcoholism is also described in this study 
where the patients continue to use alcohol inspite of tuberculosis medications 
which has a still more adverse outcome.  
   The total duration of alcohol dependence pattern in this study was found 
to be 13 years which indicates that majority were drinking over a period of 
more than 13 years.  
ALCOHOL DEPENDENCE AND PERSONALITY FACTORS: 
   Personality factors which does not have positive correlation with alcohol 
dependence are self discipline, activity, gregariousness, excitement, 
anxiousness, impulsivity, assertiveness, feelings, depressiveness, self-
consciousness, modesty, aesthetics, trust, straight forwardness, competence, 
altruism. This implies that patients with alcohol dependence reported the above 
mentioned factors only to a lesser extent and also that chances of alcohol co-
existing with the above mentioned personality factors is meager.  
    Factors which got a positive correlation with alcohol and a significant p 
value are angry hostility, vulnerability, permissive and broad mindedness 
values, tender mindedness, compliance. This replicates the results of studies 
done Choudary et al20 which says that traits of neuroticism, over protectiveness 
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and lability were highly prevelant among default patients and nearly 52% had 
neurotic traits which had high default rates and at the same time it was 
amenable to behavior modification.  
PSYCHIATRIC ILLNESS: 
    In this sample, 4 members were found to have psychiatric illness. 1 had 
auditory hallucinations alone secondary to alcohol use and 1 had depression 
with HAMD score 12. This is not in accordance with the previous studies by 
Francis et al36 which gives a 42% of depression among defaulters. Also cough 
as a independent risk factor for depression as stated by French et al112 and 80% 
prevelance of depression as stated by Muhammad Anwar et al118 is not being 
found in our study results. 1 was found to have a panic disorder with a score of 
8 in Panic Disorder Severity Scale. Chand et al66 found an association between 
panic disorder and tuberculous meningitis which was not established in our 
study as co existing neurological manifestations were excluded in our study.  
      1 patient who had 1 previous episode of mania and depression currently 
with YMRS scores-8 and under remission is reported in our study. Median 
value of 7months of unemployment was found in this group, Tuberculosis 
diagnosed in this group was found to be before 6 months, ATT adherence in 
months found to have median value of 2 months which is again an indicator 
that majority tend to discontinue the drugs at the end of intensive phase. Last 
drink in months was found to have a median value 2 months. Alcohol duration 
in years was found to have a median value of 8years.  
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    Significant association could not be established between psychiatric 
illness and alcohol dependence, co-morbid illness, prior episode of 
tuberculosis, family history of psychiatric illness, months of unemployment, 
AUDIT scores, ATT adherence in months, alcohol use in years because only  
4 of them reported to have psychiatric illness. As only 4 among the sample 
reported psychiatric illness, relationship between psychiatric illness and various 
personality factors could not be assessed in this study.  
PERSONALITY FACTORS 
     Angry hostility and impulsivity are the dominant personality factor traits 
in this study and the positive correlation between alcohol dependence with 
these factors again confirms the predominance of these 2 factors among 
defaulters and their role in drug adherence. Vulnerability, anxiousness, 
assertiveness and depressiveness are the next predominant factors in this 
population and this is in accordance with the results of previous studies by 
Immerman et al176 which have also highlighted the predominance of neurotic 
traits which were not controlled by the anti-tuberculosis medications and this 
study highlights the inclusion of psychotherapy to modify the personality 
factors to improve adherence. Our study findings also replicate the results of 
Bansal et al174 which states that among 214 participants, 54. 1% were found to 
be anxious personality when assessed with 16-Personality Questionaire.  
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CONCLUSION 
      In this study 79 members reported to abuse alcohol daily having a 
dependent pattern and nearly 64 stated alcohol as the reason for them to 
discontinue anti tuberculosis medications and this percentage is high when 
compared with the previously mentioned studies which give only less than 
30%. This shows a high prevalence of alcohol dependence among tuberculosis 
default patients and also that alcohol is an independent risk factor for 64 
members in this study to discontinue anti –tuberculosis medications which 
disproves our null hypothesis which states that there is no correlation between 
alcohol use and discontinuation of anti tuberculosis medications. But 
psychiatric illness was reported only by 4 people in this study which is less 
when compared with the previous studies where previous ones have quoted a 
high prevelance of depression among tuberculosis patients. Hence our null 
hypothesis stating no association between psychiatric illness and tuberculosis 
drug adherence is proved true. Regarding personality factors, angry, 
vulnerability, anxiousness, assertiveness, depressiveness and impulsivity were 
found to be highly prevalent among the defaulter groups and it also had a 
positive correlation with alcohol use which states that patients with these 
factors are highly prone for poor drug adherence which again disproves our 
null hypothesis. This also implies that these groups can be considered as high 
risk and to be screened during the commencement of the treatment in order to 
prevent default and relapse. Significant association between personality factors 
and psychiatric illness could not be established in this study as only 4 were 
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found to have illness. Significant association between alcohol dependence, last 
drink and AUDIT scores were also found in this study and thus highlighting the 
need for intervention to improve adherence and to prevent further default or 
relapse.  
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STRENGTH OF THE STUDY 
1.  The study was conducted in a tertiary care hospital with good 
maintenance of records regarding the drug adherence. 
2.  Standard screening module and scales with high reliability were enrolled 
in this study. 
3.  Diagnosis of tuberculosis were made within the past 6 months which 
reduced the recall bias regarding details of drug discontinuation. 
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LIMITATIONS OF THE STUDY 
1) This study is a cross sectional study done at one time.  
2) The study population in this group belonged to low socio economic status 
with lower level of education and so results cannot be generalized to the 
population. 
3) Sample size is small. Larger sampling is required for refined analysis.  
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FUTURE DIRECTIONS 
 1) This study can be conducted with control groups so that the role of these 
factors can be analyzed with more clarity and by doing so, there appears 
higher chances of generalizing the results.  
2) Longitudinal study pattern conducted throughout the 6 months period 
can throw light over the individual role of all these factors in drug 
adherence and default.  
3) Apart from screening and diagnosing, intervention at various levels with 
both drugs as well as psychotherapy can be included to assess the 
response and improvement in adherence.  
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Structured Clinical Interview for DSM-IV Axis I Disorders
Patient Edition (February 1996 FINAL)
SCID-I/P (Version 2.0)
Overview
INTERVIEW INFORMATION
Status: O In progress O Completed O Consensus reviewed
Type: O Computer O Paper
Subject ID:
Subject Initials:
Rater:
Site:
Date of Interview:
Sources of information
(check all that apply):
O Subject
O Family
O Health professional/chart/referral note
Relationship to Proband:
Edited and checked by:
Date:
Recruitment Source:
DEMOGRAPHIC DATA
I'm going to be asking you about problems or difficulties you may have had, and I'll be making some notes as we go along. Do you have
any questions before we begin?
Information
Gender: Date of Birth: Age:
What do you consider to be your ethnic origin?
Marital Status
What is your current marital status?
Dates of Marriage
Start Date End Date Comments
Children
Do you have any children? O Yes O No
Children
Gender Age Comments
Living Situation
With whom do you live?
Religion
What was your childhood religious affiliation, if any? What is your current religion, if any?
FAMILY HISTORY
Were you adopted? O Yes O No
Mother
Living: O Yes O No
Brief Description (age, current location and living situation, general disposition, etc):
Occupation:
Highest Level of Education:
Religion:
# of Siblings:
Father
Living: O Yes O No
Brief Description (age, current location and living situation, general disposition, etc):
Occupation:
Highest Level of Education:
Religion:
# of Siblings:
Do you have any siblings? O Yes O No
(If yes, note genders and ages. Also indicate half of step siblings.)
Are you close to any of your siblings?
What was it like growing up in your family?
(Briefly describe home environment and relationships, including any trauma or abuse.)
Family History Form
Interviewer: "Tell me about your biological parents, children, siblings and grandparents." Ask if they have had any problems with their mood
or anxiety or problems with drugs or alcohol. If adopted, ask about biological family; if not known, indicate "Adoptive Family" and answer
accordingly. If deceased, note both date of death and "+" symbol in current age column.
Relation Name Current
Age
Psychiatric
Symptoms
Professional
Diagnosis
(list)
Psychiatric
Treatment
Comments
DEVELOPMENTAL HISTORY
Where were you born and raised?
(Significant moves, health, school, friends, activities, etc.)
EDUCATION
How far did you get in school?
EVER FAILED TO COMPLETE A PROGRAM IN WHICH S/HE WAS ENROLLED: Why didn't you finish?
MILITARY HISTORY
Military Service: O Yes O No Branch:
End of Service:
Start of Service:
Theater:
Veteran: O Yes O No
Combat: O Yes O No
Type of Discharge:
Rank at Discharge: MOS:
Service Connected
Disability
O Yes O No Percent
Reason
WORK HISTORY
Are you working now? What is your job? How long have you
been there?
[IF LESS THAN 6 MONTHS: Why did you leave your last job?]
Have you always done this kind of work? [IF NOT: What kind of work have you done?] What is the highest level job you have ever held?
[Chronology of work history: (include longest job held and longest time unemployed)] How are you supporting yourself now? (If disability,
list type, date and reason.)
Has there ever been a period of time when you were unable to work or go to school? (When? Why was that?)
OVERVIEW OF PRESENT ILLNESS
Have you been in any kind of treatment in the past month?
[IF CURRENTLY IN TREATMENT:
Date of admission to inpatient or outpatient facility.]
CHIEF COMPLAINT
(Description of presenting problem): [RECORD DIRECT QUOTE]
What led to your coming here? What is the major problem you have been having?
HISTORY OF PRESENT ILLNESS
Do you currently have any psychiatric symptoms or emotional
problems?
O Yes O No
IF YES: When did your current symptoms begin? When were you last feeling your normal self? Is this something new or a return of
something you have had before? What was going on in your life when this began? (Environmental context for precipitants of present
illness or exacerbation) Did anything happen or change? Since this began, when have you felt the worst? (IF MORE THAN A YEAR
AGO: In the last year, when have you felt the worst?)
Have you had any other problems in the last month? What has your mood been like? How have you been spending your free time? Who
do you spend time with?
How much have you been drinking (alcohol) (in the past month)? Have you been taking any drugs (in the past month)? (What about
marijuana, cocaine, other street drugs?)
PAST PSYCHIATRIC HISTORY
When in your life did you first experience your symptoms? When was the first time you saw someone for emotional or psychiatric
problems? (What was that for? What treatment(s) did you receive? What medications?) Were there other times when you had
counseling or treatment of any kind? (What type? When?)
Age of first treatment for Depression
Age of first treatment for Mania
Age of first treatment for Hypomania
Age of first treatment for Mixed State
Age of first treatment for Psychosis/SZ
HOSPITALIZATIONS:
Have you ever been a patient in a psychiatric hospital? O Yes O No
(IF YES: When? Where? Why?)
Number of previous hospitalizations for Depression
(Do not include transfers)
Number of previous hospitalizations for Mania
Number of previous hospitalizations for Mixed State
Number of previous hospitalizations for Non-mood
Estimated lifetime total time of psychiatric hospitalization in
weeks:
SUBSTANCE/ALCOHOL TREATMENT:
Have you ever had treatment for drugs or alcohol? O Yes O No
Treatment Information:
ATTENTION DEFICIT-HYPERACTIVITY DISORDER:
Have you ever been diagnosed with Attention
Deficit-Hyperactivity Disorder?
O Yes O No
(Include symptoms, presentation, age at diagnosis, age of first symptoms and treatment)
Medication Assessment Form
Category: Class: Drug Name: Start Date: End Date: O Unknown
Multiple Trials: Duration Used: Reason Stopped: Response Type: Treatment Induced:
Comments
[Record side effect information whenever possible.]
MEDICAL HISTORY
Have you had any medical problems now or in the past? (What were they? How were they treated?) Were you ever in the hospital for
treatment of a medical problem? (What was that for?) Have you ever had any surgeries (including outpatient)? (When? What were they
for?)
O Yes O No
ALLERGIES:
Do you have any allergies? To Medications? Other?
O Yes O No
GENETIC DISORDERS:
Do you have any other genetic disorders? (What and when diagnosed?) Do you know of any genetic disorders that run in your family?
(What? Who?)
O Yes O No
THYROID DISORDER:
Have you ever been treated for a thyroid disorder? (Include diagnosis, age of diagnosis, and treatment) Was this only while on Lithium?
O Yes O No
HEAD INJURY:
Have you ever had a head injury? (Did you lose consciousness? How long? How many times have you lost consciousness due to a head
injury?)
O Yes O No
FEMALES ONLY:
Have you gone through menopause? (Have you ever had any serious emotional problems associated with menopause?)
O Yes O No
OTHER CURRENT PROBLEMS
MOST LIKELY CURRENT DIAGNOSIS
DIAGNOSES THAT NEED TO BE RULED OUT
GLOBAL ASSESSMENT OF FUNCTIONING
Current GAF
DSM-IV Axis V: Global Assessment of Functioning Scale
Consider psychological, social, and occupational functioning on a hypothetical continuum of mental health-illness. Do not include
impairment in functioning due to physical (or environmental) limitations. Indicate appropriate code for the LOWEST level of functioning
during the week of POOREST functioning. (Use intermediate level when appropriate, e.g., 45, 58, 72.)
100
91
Superior functioning in a wide range of activities, life's problems never seem to get out of hand, is sought out by others because of
his or her many positive qualities. No symptoms.
90 Absent or minimal symptoms (e.g., mild anxiety before an exam), good functioning in all areas, interested and involved in a wide
range of activities, socially effective, generally satisfied with life, no more than everyday problems or concerns (e.g., an occasional
81 argument with family members).
80
71
If symptoms are present, they are transient and expectable reactions to psychosocial stressors (e.g., difficulty concentrating after
family argument), no more than slight impairment in social, occupational, or school functioning (e.g., temporarily falling behind In
school work).
70
61
Some mild symptoms (e.g., depressed mood and mild Insomnia) OR some difficulty in social, occupational, or school functioning
(e.g., occasional truancy, or theft within the household), but generally functioning pretty well, has some meaningful interpersonal
relationships.
60
51
Moderate symptoms (e.g., flat affect and circumstantial speech, occasional panic attacks) OR moderate difficulty in social,
occupational, or school functioning (e.g., few friends, conflicts with co-workers).
50
41
Serious symptoms (e.g., suicidal ideation, severe obsessional rituals, frequent shoplifting) OR any serious impairment in social,
occupational, or school functioning (e.g., no friends, unable to keep a job).
40
31
Some impairment in reality testing or communication (e.g., speech is at times illogical, obscure, or irrelevant) OR major impairment
in several areas, such as work or school, family relations, judgment, thinking, or mood (e.g., depressed man avoids friends, neglects
family, and is unable to work; child frequently beats up younger children, Is defiant at home, and is failing at school).
30
21
Behavior is considerably influenced by delusions or hallucinations OR serious impairment in communication or judgment (e.g.,
sometimes Incoherent, acts grossly inappropriately, suicidal preoccupation) OR inability to function in almost all areas (e.g., stays in
bed all day; no job, home, or friends)
20
11
Some danger of hurting self or others (e.g., suicide attempts without clear expectation of death, frequently violent, manic excitement)
OR occasionally fails to maintain minimal personal hygiene (e.g., smears feces) OR gross impairment in communication (e.g.,
largely incoherent or mute)
10
1
Persistent danger of severely hurting self or others (e.g., recurrent violence) OR persistent inability to maintain minimal personal
hygiene OR serious suicide act with clear expectation of death
Module A: Depression
MAJOR AND MINOR DEPRESSIVE EPISODES
Episodes Summary
Date of Onset Age Date of Offset Duration (days)
A - CURRENT (LAST MONTH) O Go There
B - WORST EPISODE O Go There
C - FIRST
EPISODE
O Go There
D - ANOTHER EPISODE O Go There
E - ANOTHER EPISODE O Go There
Episode A: Current Depression
INFORMATION TO PARTICIPANTS 
Title: A STUDY ON  PREVALENCE OF PSYCHIATRIC  
CO-MORBIDITY, ALCOHOL ABUSE,PERSONALITY  
FACTORS IN TUBERCULOSIS DEFAULT PATIENTS 
 
Principal Investigator: Dr.Vishnu Priya.v 
Name of Participant: 
Site: Government Thiruvoteeswarar Tuberculosis Hospital,Otteri,Chennai 
You are invited to take part in this research. The information in this document is 
meant to help you decide whether or not to take part. Please feel free to ask if you have 
any queries or concerns. 
What is the purpose of research. 
Tuberculosis is a chronic debilitating illness especially in countries like India.Drug adherence is 
very important in this illness.Poor adherence results in increased chances of default,relapse and 
drug resistance. We want to assess the Prevalence of psychiatric co-morbidity,alcohol 
abuse,personality factors in tuberculosis default patients 
We have obtained permission from the Institutional Ethics Committee. 
The study design and procedures: 
20 - 60 years aged in patients admitted and diagnosed as lost to follow up or default are enrolled 
in this study. The following scales are given to them in one setting. 
The instruments used are: 
SCID-Structured Clinical Interview in DSM-5 
.  PDSS-Panic disorder severity scale 
 Hamilton’s depression rating scale. 
 Young mania rating scale. 
 Alcohol use disorder identification test ( AUDIT) 
    5 Factor Personality Self Rating Form  
. 
 
Confidentiality of the information obtained from you 
You have the right to confidentiality regarding the privacy of your medical 
information (personal details, results of physical examinations, investigations, and 
your medical history). By signing this document, you will be allowing the research 
team investigators, other study personnel, Institutional Ethics Committee and any 
person or agency required by law like the Drug Controller General of India to view 
your data, if required. 
The information from this study, if published in scientific journals or presented at 
scientific meetings, 
will not reveal your identity. 
How will your decision to not participate in the study affect you? 
Your decision not to participate in this research study will not affect your 
medical care or your relationship with the investigator or the institution. You will be 
taken care of and you will not loose any benefits to which you are entitled. 
Can you decide to stop participating in the study once you start? 
The participation in this research is purely voluntary and you have the right to 
withdraw from this study at any time during the course of the study without giving 
any reasons. However, it is advisable that you talk to the research team prior to 
discontinuing form the study. 
Signature of Investigator Signature of Participant 
Signature of the Guardian 
Date  
  
INFORMED CONSENT FORM 
(This is only a guideline – Relevant changes to be made as per the study 
requirements) 
Title of the study: “A STUDY  ON  PREVALENCE OF PSYCHIATRIC CO-
MORBIDITY,ALCOHOL ABUSE,PERSONALITY FACTORS IN 
TUBERCULOSIS DEFAULT PATIENTS”. 
 
Name of the Participant: 
______________________________________________________. 
Name of the Principal (Co-Investigator): _Dr. Vishnu Priya. V 
Name of the Institution:Government Thiruvoteeswarar tuberculosis hospital, Otteri, 
Chennai 
_____________________________________________________. 
Name and address of the sponsor / agency (ies) (if 
any):__No________________________________ 
______________________________________________________________________. 
 
Documentation of the informed consent 
 
I _____________________________ have read the information in this form (or it has 
been read to me). I was free to ask any questions and they have been answered. I am 
over 18 years of age and, exercising my free power of choice, hereby give my consent 
to be included as a participant in 
 
“A STUDY ON  PREVALENCE OF PSYCHIATRIC CO-MORBIDITY, 
ALCOHOL ABUSE, PERSONALITY FACTORS IN TUBERCULOSIS 
DEFAULT PATIENTS”. 
1. I have read and understood this consent form and the information provided to me. 
2. I have had the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained about my rights and responsibilities by the investigator. 
5. I have been informed the investigator of all the treatments I am taking or have 
taken in the past ________ months including any native (alternative) 
treatment. 
6. I have been advised about the risks associated with my participation in this study.* 
7. I have not participated in any research study within the past 
_________month(s). * 
8. I have not donated blood within the past _______ months—Add if the study 
involves extensive blood sampling. * 
9. I am aware of the fact that I can opt out of the study at any time without 
having to give any reason and this will not affect my future treatment in this 
hospital. * 
10. I am also aware that the investigator may terminate my participation in the 
study at any time, for any reason, without my consent. * 
11. I hereby give permission to the investigators to release the information 
obtained from me as result of participation in this study to the sponsors, 
regulatory authorities, Govt. agencies, and IEC. I understand that they are 
publicly presented. 
12. I have understand that my identity will be kept confidential if my data are 
publicly presented 
13. I have had my questions answered to my satisfaction. 
14. I have decided to be in the research study. 
I am aware that if I have any question during this study, I should contact the 
investigator. By signing this consent form I attest that the information given in this 
document has been clearly explained to me and understood by me, I will be given 
a copy of this consent document. 
For adult participants: 
Name and signature / thumb impression of the participant (or legal representative if 
participant incompetent) 
Name _________________________ Signature_________________ 
Date________________ 
Name and Signature of impartial witness (required for illiterate patients): 
Name _________________________ Signature_________________ 
Date________________ 
Address and contact number of the impartial witness: 
Name and Signature of the investigator or his representative obtaining consent: 
Name _________________________ Signature_________________ 
Date________________ 
Name and Signature of the investigator or his representative obtaining consent : 
Name _________________________ Signature_________________ 
Date________________ 
 
  


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 


 
 
 
 
 





 











 
 

http://www.drugabuse.gov/nidamed-medical-health-professionals
AUDIT
Introduction
The Alcohol Use Disorders Identification Test (AUDIT) is a 10-item 
screening tool developed by the World Health Organization (WHO) to 
assess alcohol consumption, drinking behaviors, and alcohol-related 
problems. Both a clinician-administered version (page 1) and a self-report 
version of the AUDIT (page 2) are provided. Patients should be encouraged 
to answer the AUDIT questions in terms of standard drinks. A chart 
illustrating the approximate number of standard drinks in different alcohol 
beverages is included for reference. A score of 8 or more is considered to 
indicate hazardous or harmful alcohol use. The AUDIT has been validated 
across genders and in a wide range of racial/ethnic groups and is well-
suited for use in primary care settings. Detailed guidelines about use of the 
AUDIT have been published by the WHO and are available online:  
http://whqlibdoc.who.int/hq/2001/who_msd_msb_01.6a.pdf
The Alcohol Use Disorders Identification Test: Interview Version
Read questions as written. Record answers carefully. Begin the AUDIT by saying 
“Now I am going to ask you some questions about your use of alcoholic beverages 
during this past year.” Explain what is meant by “alcoholic beverages” by using 
local examples of beer, wine, vodka, etc. Code answers in terms of “standard 
drinks”. Place the correct answer number in the box at the right.
1. How often do you have a drink containing alco-
hol?
(0) Never [Skip to Qs 9-10]
(1) Monthly or less
(2) 2 to 4 times a month
(3) 2 to 3 times a week
(4) 4 or more times a week
2. How many drinks containing alcohol do you have
on a typical day when you are drinking?
(0) 1 or 2
(1) 3 or 4
(2) 5 or 6
(3) 7, 8, or 9
(4) 10 or more
3. How often do you have six or more drinks on one
occasion?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
Skip to Questions 9 and 10 if Total Score
for Questions 2 and 3 = 0
4. How often during the last year have you found
that you were not able to stop drinking once you
had started?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
5. How often during the last year have you failed to
do what was normally expected from you
because of drinking?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
6. How often during the last year have you needed
a first drink in the morning to get yourself going
after a heavy drinking session?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
7. How often during the last year have you had a
feeling of guilt or remorse after drinking?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
8. How often during the last year have you been
unable to remember what happened the night
before because you had been drinking?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
9. Have you or someone else been injured as a
result of your drinking?
(0) No
(2) Yes, but not in the last year
(4) Yes, during the last year
10. Has a relative or friend or a doctor or another
health worker been concerned about your drink-
ing or suggested you cut down?
(0) No
(2) Yes, but not in the last year
(4) Yes, during the last year
Record total of specific items here
If total is greater than recommended cut-off, consult User’s Manual.
0 1 2 3 4
The Alcohol Use Disorders Identification Test: Self-Report Version
PATIENT: Because alcohol use can affect your health and can interfere with certain 
medications and treatments, it is important that we ask some questions about 
your use of alcohol. Your answers will remain confidential so please be honest. 
Place an X in one box that best describes your answer to each question.
Questions
1. How often do you have Never Monthly 2-4 times 2-3 times 4 or more
a drink containing alcohol? or less a month a week times a week
2. How many drinks containing 1 or 2 3 or 4 5 or 6 7 to 9 10 or more
alcohol do you have on a typical
day when you are drinking?
3. How often do you have six or Never Less than Monthly Weekly Daily or 
more drinks on one monthly almost 
occasion? daily
4. How often during the last Never Less than Monthly Weekly Daily or 
year have you found that you monthly almost 
were not able to stop drinking daily
once you had started?
5. How often during the last Never Less than Monthly Weekly Daily or
year have you failed to do monthly almost 
what was normally expected of daily
you because of drinking?
6. How often during the last year Never Less than Monthly Weekly Daily or
have you needed a first drink monthly almost 
in the morning to get yourself daily
going after a heavy drinking
session?
7. How often during the last year Never Less than Monthly Weekly Daily or
have you had a feeling of guilt monthly almost 
or remorse after drinking? daily
8. How often during the last year Never Less than Monthly Weekly Daily or
have you been unable to remem- monthly almost 
ber what happened the night daily
before because of your drinking?
9. Have you or someone else No Yes, but Yes,
been injured because of not in the during the
your drinking? last year last year
10.Has a relative, friend, doctor, or No Yes, but Yes, 
other health care worker been not in the during the 
concerned about your drinking last year last year
or suggested you cut down?
Total
  STANDARD 
DRINK 
EQUIVALENTS 
 APPROXIMATE  
NUMBER OF  
STANDARD DRINKS IN: 
  
  
   BEER or COOLER 
12 oz. 
 
~5% alcohol 
12 oz. = 1 
16 oz. = 1.3 
22 oz. = 2 
40 oz. = 3.3 
   MALT LIQUOR 
8-9 oz. 
~7% alcohol 
12 oz. = 1.5 
16 oz. = 2 
22 oz. = 2.5 
40 oz. = 4.5 
   TABLE WINE 
 
5 oz. 
 
~12% alcohol 
a 750 mL (25 oz.) bottle = 5 
  80-proof SPIRITS (hard liquor) 
1.5 oz. 
 
~40% alcohol 
 
 
 
 
 
 
 
 
 
 
 
 
 
a mixed drink = 1 or more* 
a pint (16 oz.) = 11 
a fifth (25 oz.) = 17 
1.75 L (59 oz.) = 39 
*Note: Depending on factors such as the type of spirits and the recipe, one mixed 
drink can contain from one to three or more standard drinks. 
http://pubs.niaaa.nih.gov/publications/Practitioner/pocketguide/pocket_guide2.htm 




  
Panic Disorder Severity Scale – Self Report Form 
 
Several of the following questions refer to panic attacks and limited symptom attacks.  For this questionnaire we 
define a panic attack as a sudden rush of fear or discomfort accompanied by at least 4 of the symptoms listed below.  
In order to qualify as a sudden rush, the symptoms must peak within 10 minutes.  Episodes like panic attacks but 
having fewer than 4 of the listed symptoms are called limited symptom attacks.  Here are the symptoms to count: 
 
•  Rapid or pounding heartbeat              •  Chest pain or discomfort      •  Chills or hot flushes 
•  Sweating    •  Nausea        •  Fear of losing control or  
•  Trembling or shaking               •  Dizziness or faintness                      going crazy 
•  Breathlessness   •  Feelings of unreality                   •  Fear of dying 
•  Feeling of choking   •  Numbness or tingling       
                       
1.   How many panic and limited symptoms attacks did you have during the week? 
       
0 No panic or limited symptom episodes 
1 Mild: no full panic attacks and no more than 1 limited symptom attack/day 
2 Moderate: 1 or 2 full panic attacks and/or multiple limited symptom attacks/day 
3 Severe: more than 2 full attacks but not more than 1/day on average 
4 Extreme: full panic attacks occurred more than once a day, more days than not 
 
2.    If you had any panic attacks during the past week, how distressing (uncomfortable, frightening) were they 
       while they were happening?  (If you had more than one, give an average rating.  If you didn’t have any  
       panic attacks but did have limited symptom attacks, answer for the limited symptom attacks.) 
 
0 Not at all distressing, or no panic or limited symptom attacks during the past week 
1 Mildly distressing (not too intense) 
2 Moderately distressing (intense, but still manageable) 
3 Severely distressing (very intense) 
4 Extremely distressing (extreme distress during all attacks) 
 
3.    During the past week, how much have you worried or felt anxious about when your next panic attack would 
       occur or about fears related to the attacks (for example, that they could mean you have physical or mental 
       health problems or could cause you social embarrassment)? 
 
0 Not at all 
1 Occasionally or only mildly 
2 Frequently or moderately 
3 Very often or to a very disturbing degree 
4 Nearly constantly and to a disabling extent 
 
4.    During the past week were there any places or situations (e.g., public transportation, movie theaters, crowds, 
       bridges, tunnels, shopping malls, being alone) you avoided, or felt afraid of (uncomfortable in, wanted to avoid  
       or leave), because of fear of having a panic attack?  Are there any other situations that you would have avoided 
       or been afraid of if they had come up during the week, for the same reason?  If yes to either question, please 
       rate your level of fear and avoidance this past week.   
 
0 None: no fear or avoidance 
1 Mild:  occasional fear and/or avoidance but I could usually confront or endure the situation.  There was 
little or no modification of my lifestyle due to this. 
2 Moderate: noticeable fear and/or avoidance but still manageable.  I avoided some situations, but I could 
confront them with a companion.  There was some modification of my lifestyle because of this, but my 
overall functioning was not impaired.   
3 Severe:  extensive avoidance.  Substantial modification of my lifestyle was required to accommodate the 
avoidance making it difficult to manage usual activities.  
4 Extreme: pervasive disabling fear and/or avoidance.  Extensive modification in my lifestyle was required 
such that important tasks were not performed.   
 
 
 
Name:_________________________________________                                  Date:____________________ 
  
 
5.    During the past week, were there any activities (e.g., physical exertion, sexual relations, taking a hot shower or 
       bath, drinking coffee, watching an exciting or scary movie) that you avoided, or felt afraid of (uncomfortable  
       doing, wanted to avoid or stop), because they caused physical sensations like those you feel during panic  
       attacks or that you were afraid might trigger a panic attack? Are there any other activities that you would have 
       avoided or been afraid of if they had come up during the week for that reason?  If yes to either question, please 
       rate your level of fear and avoidance of those activities this past week.   
 
0 No fear or avoidance of situations or activities because of distressing physical sensations 
1 Mild: occasional fear and/or avoidance, but usually I could confront or endure with little distress activities 
that cause physical sensations.  There was little modification of my lifestyle due to this. 
2 Moderate: noticeable avoidance but still manageable.  There was definite, but limited, modification of my 
lifestyle such that my overall functioning was not impaired.   
3 Severe:  extensive avoidance.  There was substantial modification of my lifestyle or interference in my 
functioning. 
4 Extreme: pervasive and disabling avoidance.  There was extensive modification in my lifestyle due to this 
such that important tasks or activities were not performed.        
 
6.    During the past week, how much did the above symptoms altogether (panic and limited symptom attacks,  
       worry about attacks, and fear of situations and activities because of attacks) interfere with your ability to work 
       or carry out your responsibilities at home?   (If your work or home responsibilities were less than usual this past 
       week, answer how you think you would have done if the responsibilities had been usual.)    
 
0 No interference with work or home responsibilities 
1 Slight interference with work or home responsibilities, but I could do nearly everything I could if I didn’t  
have these problems. 
2 Significant interference with work or home responsibilities, but I still could manage to do the things I 
needed to do. 
3 Substantial impairment in work or home responsibilities; there were many important things I couldn’t do 
because of these problems. 
4 Extreme, incapacitating impairment such that I was essentially unable to manage any work or home 
responsibilities.   
 
7.    During the past week, how much did panic and limited symptom attacks, worry about attacks and fear of  
       situations and activities because of attacks interfere with your social life?  (If you didn’t have many opportunities 
       to socialize this past week, answer how you think you would have done if you did have opportunities.) 
 
0 No interference 
1 Slight interference with social activities, but I could do nearly everything I could if I didn’t have these 
problems. 
2 Significant interference with social activities but I could manage to do most things if I made the effort. 
3 Substantial impairment in social activities; there are many social things I couldn’t do because of these 
problems. 
4 Extreme, incapacitating impairment, such that there was hardly anything social I could do. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scoring the Panic Disorder Severity Scale 
 
 
In scoring the Panic Disorder Severity Scale, items are rated on a scale of 0 to 4.  A composite score  
is established by averaging the scores of the seven items.  The table below can be used to convert 
raw scores (sum of individual item scores) into composite scores.   
 
 
Raw 
Score 
Composite 
Score 
Raw 
Score 
Composite 
Score 
Raw 
Score 
Composite  
Score 
Raw 
Score 
Composite 
Score 
0 0 7 1.00 14 2.00 21 3.00 
1 .14 8 1.14 15 2.14 22 3.14 
2 .28 9 1.28 16 2.28 23 3.28 
3 .42 10 1.42 17 2.42 24 3.42 
4 .57 11 1.57 18 2.57 25 3.57 
5 .71 12 1.71 19 2.71 26 3.71 
6 .85 13 1.85 20 2.85 27 3.85 
      28 4.00 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright notice:  The Panic Disorder Severity Scale – Self Report Form is copyrighted by 
                M. Katherine Shear, M.D.  Permission has been granted to reproduce the scale 
                on this website for clinicians to use in their practice and for researchers to use in 
            non-industry studies.  For other uses of the scale, the owner of the copyright should 
               be contacted.   
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Young Mania Rating Scale (YMRS) 
 
Guide for Scoring Items – The purpose of each item is to rate the severity of that abnormality in the patient.  When several 
keys are given for a particular grade of severity, the presence of only one is required to qualify for that rating. 
 The keys provided are guides.  One can ignore the keys if that is necessary to indicate severity, although this should be 
the exception rather than the rule. 
 Scoring between the points given (whole or half points) is possible and encouraged after experience with the scale is 
acquired.  This is particularly useful when severity of a particular item in a patient does not follow the progression indicated 
by the keys. 
 
1. Elevated Mood 
0 Absent 
1 Mildly or possibly increased on questioning 
2 Definite subjective elevation; optimistic, self-
confident; cheerful; appropriate to content 
3 Elevated, inappropriate to content; humorous 
4 Euphoric; inappropriate to content; singing 
 
2. Increased Motor Activity – Energy 
0 Absent 
1 Subjectively increased 
2 Animated; gestures increased 
3 Excessive energy; hyperactive at times; restless 
(can be calmed) 
4 Motor excitement; continuous hyperactivity 
(cannot be calmed) 
 
3. Sexual Interest 
0 Normal; not increased 
1 Mildly or possibly increased 
2 Definitive subjective increase on questioning 
3 Spontaneous sexual content; elaborates on sexual 
matters; hypersexual by self-report 
4 Overt sexual acts (towards patients, staff, or 
interviewer) 
 
4. Sleep 
0 Reports no decrease in sleep 
1 Sleeping less than normal amount by up to one 
hour 
2 Sleeping less than normal by more than one hour 
3 Reports decreased need for sleep 
4 Denies need for sleep 
 
5. Irritability 
0 Absent 
2 Subjectively increased 
4 Irritable at times during interview; recent 
episodes of anger or annoyance on ward 
6 Frequently irritable during interview; short, curt 
throughout 
8 Hostile, uncooperative; interview impossible 
 
6. Speech (Rate and Amount) 
0 No increase 
2 Feels talkative 
4 Increased rate or amount at times, verbose at 
times 
6 Push; consistently increased rate and amount; 
difficult to interrupt 
8 Pressured; uninterruptible, continuous speech 
7. Language – Thought Disorder 
0 Absent 
1 Circumstantial; mild distractibility; quick 
thoughts 
2 Distractible; loses goal of thought; changes 
topics frequently; racing thoughts 
3 Flight of ideas; tangentiality; difficult to follow; 
rhyming; echolalia 
4 Incoherent; communication impossible 
 
8. Content 
0 Normal 
2 Questionable plans, new interests 
4 Special project(s); hyperreligious 
6 Grandiose or paranoid ideas; ideas of reference 
8 Delusions; hallucinations 
 
9. Disruptive – Aggressive Behavior 
0 Absent; cooperative 
2 Sarcastic; loud at times; guarded 
4 Demanding; threats on ward 
6 Threatens interviewer; shouting; interview 
difficult 
8 Assaultive; destructive; interview impossible 
 
10. Appearance 
0 Appropriate dress and grooming 
1 Minimally unkempt 
2 Poorly groomed; moderately disheveled; 
overdressed 
3 Disheveled; partly clothed; garish makeup 
4 Completely unkempt; decorated; bizarre garb 
 
11. Insight 
0 Present; admits illness; agrees with need for 
treatment 
1 Possibly ill 
2 Admits behavior change, but denies illness 
3 Admits possible change in behavior, but denies 
illness 
4 Denies any behavior changes 
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NANDAN 37 M 3 <2 CHOOLAI M H 1 8 1 Y 36 N A PANICN N 1 0 8 DEPRESTB-F 0 0 0 0 0 0 0 0 0 4 4 4 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
KRISHNAN 37 M 6 >2 MMDA M H 15 1 1 Y 30 N NAUSEA N DCLD N 3 0 3 0 0 0 0 0 0 0 0 0 0 0 0 5 5 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
VEERASAMY 36 M 5 <2 KOVILAMBAKKAM UM H 12 6 2 Y 30 C,H,M A N N N 2 0 10 ADS-F CKD-M 0 0 0 0 0 0 0 0 0 5 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
CHINAPAL 45 M 5 <2 VILLIVAKKAM UM H 8 2 0 Y 36 B POOR FA  N N N 3 0 10 ADS-F 0 HAM0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SIVALINGAM 38 M 6 <2 PULIYANTHOPU M H 24 6 2 Y 38 N A N N N 3 0 18 ADS-F 0 0 0 0 0 0 0 0 0 0 0 4 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SELVAM 35 M 3  <2    UM H 36 6 4 Y 34 N FELT GOO  N N N 2 0 12 SUICID 0 0 0 0 0 0 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
DAMODHARAN 60 M 8 >2 KOLATHUR M H 8 6 5 N 0 B DISTANC  N N N 0 0 0 ADS-EB0 0 0 0 0 0 0 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
PUTHIYARAJ 36 M 9 >2 MOOLAKUM M,S H 1.5 6 4 Y 36 N A N N N 2.5 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
ARUNACHALAM 44 M ILLITRATE <2 THANDAYARPET M H 24 4 2 Y 40 N A N N N 1 0 15 0 0 0 1 5 A 0 0 0 0 0 0 5 5 0 0 0 0 3 5 0 0 0 0 0 0 0 0 0 0 0 0 0
ANBU             45 M ILLITRATE >2 PATTALUM   M H 8 5 1 Y 36 N A N N N 0.3 0 15 0 0 0 0 0 0 0 0 0 0 0 5 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
NANDAKUMAR 38 M 5 >2 WASHERMENPET M C 6 3.5 0.34 Y 38 N A N N N 5 0 18 0 MI-F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 4 4 0 0 0 0 0 0 0 0 0 0 0
TAMIZHARASAN 56 M 4 >2 MADHAVARAM M H 0 6 5 N 0 N FEELGOO  N N N 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
CHARLES 50 M 5 <2 CHOOLAI M C 3 5 2 Y 38 N A N N N 1 0 20 CANNA0 0 3 4 A 0 0 0 0 0 0 0 0 4 0 0 0 0 0 4 0 4 0 0 0 0 0 0 0 0 0 0
RAVI 45 M ILLITRATE <2 AMINJIKARAI M H 36 6 4 Y 38 N A N N N 3 0 25 ADS-F,E0 0 0 0 0 0 0 0 0 0 4 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
KUMAR 40 M ILLITRATE <2 AYANAVARAM M H 4 4 2 Y 40 M A BPAD-DM N 1 0 9 ADS-3E0 0 0 0 0 0 0 0 0 0 0 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
KUPPAN 32 M 7 >2 VEPPERY M H 1 3 0.33 Y 38 N A N N N 0.8 0 4 0 0 0 0 0 0 0 0 0 0 0 5 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
GAJENDRAN 68 M ILLITRATE >2 AMBATTUR M C 0.5 1 0.2 N 0 H ITCHING N N N 60 0 0 0 0 0 0 0 0 0 0 ADS15 8 0 0 0 0 0 0 0 0 0 4 0 4 0 0 0 0 0 0 0 0 0 0
MARI 35 M ILLITRATE >2 OTTERI M H 0 5 2 Y 38 CDS-8Y A N N N 2 0 15 ADS-F 0 0 0 0 0 0 0 0 0 0 0 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
AMBIKA 65 F ILLITRATE >2 VILLIVAKKAM M H 0 6 3 Y 36 N HUSBAN  N N N 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 4 4 0 0 0 0 0 0 0
DOMINIC 60 M 7 0 SAIDAPET M C 0 5 4 Y 36 B DISTANCE N N 2 0 40 0 0 0 0 0 0 0 0 0 0 0 0 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SARAVANAN   38 M 4 <2 VIRUGAMBAKKAM UM H 2 6 4 Y 38 CDS-5Y,CIGARET N N N 60 0 0 ADS-F 0 0 0 0 0 0 0 ADS15 15 0 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
VELAN 42 M 7 <2 OTTERI UM H 60 6 5 Y 38 N A N APD N 1 0 20 ADS-F MI-M 0 2 1 A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 0
NEELAKANDAN 43 M 7 >2 KOLATHUR M H 3 3 1 Y 32 N UNABLE  N N N 2 0 20 M-SUIC0 0 2 3 A 0 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
ANBAZHAGAN 56 M 10 >2 VELLORE M H 1 4 3 N 7 N WORK N N N 4 0 7 0 DM-F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 0
RAMALINGAM 58 M ILLITRATE <2 AMBATUR M H 6 5 2 N 0 N NAUSEA N N N 12 0 5 ADS-F 0 0 0 0 0 0 0 ADS5 1 0 3 3 0 0 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 0
SOUNDARRAJAN 52 M 10 >2 TPSATTIRAM M H 12 13 0.5 Y 30 N WORK N N N 1 0 1 ADS-F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0
MAHENDRAN 49 M BSC 0 THIRUMULAIVAYIL  M H 24 4 2 Y 38 N A N N N 1 0 2 YB-SUIC0 0 0 0 0 0 0 0 0 0 5 5 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SELVAM 29 M ILLITRATE <2 KORUKUPET UM H 5 6 3 Y 40 N A N N N 3 0 10 ADS-F,20 0 0 0 0 0 0 0 0 0 0 5 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
BALAJI 41 M B.COM <    2 CHOOLAI M H 6 6 2 Y 38 N A N N N 2 0 15 PSYCHO0 0 0 0 0 0 0 0 0 0 4 5 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
DHANASEKAR 40 M 10 >2 VYASAARPADI M H 12 5 3 Y 38 N A N N N 1 0 8 0 SHT-M 0 0 0 0 0 0 0 0 0 5 4 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
NAGAPPAN 50 M 3 <2 VYASARPADI M H 36 6 2 Y 40 N A N N N 2 0 25 0 0 0 0 0 0 0 0 0 0 0 4 5 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SIGMNI 37 M 8 <2 VADAPALANI M H 4 3 0.5 Y 36 N A N N N 3 0 10 ADS-F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
GANDI              77 M 2 0 VELLORE M H 0 4 1 Y 30 N A N N N 1 0 25 ADS-F 0 0 15 4 A 20 0 0 0 0 0 4 5 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
MICHAEL 56 M 7 <2 VYASARPADI M C 60 3 1 Y 20 B,C GIDDINE N N N 1 0 40 0 0 0 0 0 0 0 0 0 0 0 3 3 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SELVAM 37 M ILLITRATE <2 PULIYANTHOPU UM H 12 4 2 N 0 B,C GIDDINE N N N 6 Y 9 ADS-EBF-TB,M-D   0 5 3 WORK 0 0 ADS9 6 3 0 4 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
KUMAR 42 M 10 <2 NSKNAGAR W H 12 6 3 N 0 N SKIN ERUN N N 24 0 5 0 0 0 6 3 FELTGO   0 0 ADS5 2 0 0 0 0 0 0 4 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0
PAUL                60 M 12 0 EGMORE M C 0 6 2 N 6 N NAUSEA N N N 1 Y 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 4 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0
RAJINI 41 M ILLITRATE <2 CENTRAL M H 3 4 2 Y 18 N A N DM N 3 0 30 ADS-F,EMI-M,TB-ES    2 4 DM 30 0 0 0 0 0 0 0 0 0 3 4 0 0 4 0 0 0 0 0 4 0 0 0 0 0 0
RAMU 45 M ILLITRATE <2 VYASARPADI M H 48 6 4 Y 18 N A N N N 1 0 20 ADS-3BTB-F,TB-E    0 3 4 A                                  0 4 0 0 0 0 0 0 3 0 0 0 0 0 5 0 0 4 0 0 0 0 0 0 0 0 0
VEMBULI 70 M ILLITRATE <2 SAIDAPEET M CC 36 4 2 Y 18 N POOR  SO   N DCLD N 3 0 30 0 0 0 0 0 0 0 0 0 0 0 4 3 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
RAMESH 32 M ILLITRATE    >2                                               SATHYANAGAR M H 1.5 6 4 Y 20 C A N N N 0.5 0 7 ADS-F TB-F,M 0 1 4 A 0 0 0 0 0 0 3 0 0 4 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 0
RAJENDRAN 50 M 10 <2 KOLATHUR M H 7 6 2 Y 18 B LEGAL PRN N N 2 0 15 0 TB-EB 0 0 0 0 0 0 0 0 0 0 2 4 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
JOHN 35 M 6 >2 WASHERMENPET M C 12 8 1 Y 18 H A N N N 2 0 10 0 TB-F 0 6 5 A 0 0 0 0 0 0 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
MUTHU 50 M ILLITRATE >2 MAHARANI THEATR M H 12 5 2 Y 16 N A N N N 0.1 0 10 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
KRISHNAN 37 M 7 >2 KOYEMBEDU M H 8 5 1 N 0 N KIDNEY PN N N 12 0 8 ADS-F TB-EB 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0
RAJESH 35 M B.COM >2 MRCNAGR   M H 60 4 0.1 Y 18 N A N N N 0.5 0 13 0 CAD -EB       0 0 0 0 0 0 0 0 0 3 0 3 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SESAIAH 53 M 9 >2 REDHILLS M H 18 4 1 N 0 N POOR  SUN N N 36 0 0 ADS-EB0 0 5 4 A 30 0 ADS8 3 4 0 4 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SARAVANAN 37 M 6 >2 EGMORE M H 6 6 4 N 0 N NAUSEA N DM,SHN 8 Y 3 0 0 0 2 6 A 0 0 0 0 0 4 0 5 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0
VINOTH 28 M 8 >2 NAMALWARPET UM H 3 2 1 Y 18 ARECANGIDDINESS            SZ N 2 0 5 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0
HUMYUN 44 M 3 <2 OLDWASHERMENPEM M 60 6 2 Y 20 B,C A N N N 0.1 0 10 0 0 0 3 4 GIDDIN 40 0 0 0 0 3 0 4 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
PERUMAL 48 M 3 >2 PARRYS       M H 7 6 4 Y 20 N A N N N 2 0 20 ADS-2YTB-F 0 0 0 0 0 0 0 0 0 0 3 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SUBRAMANIAN 55 M 8 >2 ENNORE M H 3 4 1 Y 20 N A N N N 0.5 0 30 0 0 0 0 0 0 0 0 0 0 0 0 3 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
DURAKASAMY 66 M 4 <2 PERAMBUR M H 60 2 1 Y 20 ARECA FAMILY CN N N 1 0 40 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 0 4 0 0 0 0 0 0
MOORTY          62 M 6 >2 OTTERI M H 12 6 4 Y 34 B,C A N N N 0.1 0 4 0 F-THROAT 0 0 0 0 0 0 0 0 0 0 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SUDAKAR 46 M 6 >2 ROYPETTAH M H 12 6 3 N 0 B,C DINT KNO   N N N 72 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 5 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0
USMANBASHA 56 M ILLITRATE <2 WASHERMENPET M H 3 6 3 N 0 B,C B,C N N N 36 0 0 0 0 0 2 4 WORK 25 0 ABU5 3 0 4 5 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
MARIMUTHU 41 M 9 <2 KOYAMBEDU M H 18 4 2 N 0 N NAUSEA N N N 118 0 0 0 0 0 2 4 A 0 0 ADS3 1.5 0 4 5 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SHANMUGAM 55 M ILLITRATE <2 WASHERMENPET M H 1.5 4.5 0.5 Y 36 N A N N N 1.5 0 25 0 MI-F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 4 4 0 0 0
SELVAM 29 M ILLITRATE <2 KORUKUPET M C 8 8 4 Y 34 N A N N N 1 0 11 0 DM-M 0 1.5 4 A 0 0 0 0 0 0 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
NAZIR 36 M 9 <2 VILLIVAKKAM M I 24 3 1 N 0 N FELT GOON N N 24 0 16 0 0 0 1 3 FELT GO0 0 ADS16 2 4 5 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
VELU 42 M ILLITRATE <2 PATTALUM  M H 3 8 2 N 36 N A AH N N 4 0 20 0 0 0 3 4 ANGER 80 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 4 0 0 0 0 0 0 0 0 0
KAMALA 70 F 4 0 MADHAVARAM M H 60 6 2 N 0 N POOR SO  N N N 0 0 0 0 0 0 2 4 POOR S  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 4 0 0 0 0 0 0
RAGU 50 M 9 >2 AYNPAKKAM M H 18 12 3 N 0 N DIABETESN N N 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 5 0 0 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0
FAHEETA 26 F 9 0 PERAMBUR M I 0 24 3 N 0 N ULCER FON N N 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0
SASIKUMAR 43 M 4 <2 PULIANTHOPU M H 3.5 1 0.35 Y 30 N A N N N 0.5 0 6.5 0 0 0 0 0 0 0 0 0 0 0 0 4 4 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SURESH 55 M 10 <2 MINT M H 12 8 3 Y 34 N A N N N 2 0 25 ADS-F 0 0 0 0 0 0 0 0 0 0 0 4 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
VIVEK 38 M 4 <2                                       ERNAVOOR UM H 2 2 1 Y 16 N A N N N 0.5 0 2 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SARAVANAN    38 M 2 <2 VANDAVASI M H 6 12 4 N 0 B DINT KNO   N N N 2 0 5 ADS-F 0 0 2 4 UNAWA0 0 ADS3 5 3 3 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
AYYANAR 50 M ILLITRATE <2 PERIYARNAGAR W H 60 3 0.11 Y 40 B,C A N N N 2 0 15 0 0 0 1 4 A 1 0 0 0 0 0 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SUBRAMANIAN 75 M 8 >2 WALLAJA M H 3 3 0.1 N 0 B NAUSEA N N N 24 0 0 0 0 0 0 0 0 0 0 ABU3 1.5 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0
YACOB 48 M ILLITRATE >2 ANDHRAPRADESH M C 8 3 1 Y 40 B,C NAUSEA N N N 2 0 0 0 TB-S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 4 0
RAJENDRAN 44 M 10 >2 KOLATHUR M H 4 2 1 Y 36 N A N N N 1.5 0 5 0 TB-F 0 0 0 0 0 1 0 0 0 0 3 3 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
RAMADAS 45 M ILLITRATE <2 VILLIVAKKAM M H 8 2 8 Y 38 B,H,C NAUSEA N N N 3 0 25 ADS-F TB-F 0 1 4 NAUSEA2 0 0 0 0 0 4 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
NAZEMA 35 F 7 0 PULIANTHOPU M M 0 2 1 N 0 N VOMITINN N N 0 0 0 0 EPILEPSY- 0 3 2 NAUSEA0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 4 0 0 0 0 0 0 4
PORKODI 24 F 11 0 ROYAPETTAH M H 0 7 3 N 0 N ANGER F N N N 0 0 0 ADS-F 0 0 1 4 UNAWA30 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0
NITHYA 47 M 4 >2 OTTERI M H 3 18 2 Y 28 C A N N N 0.1 0 37 0 TB-F 0 0 0 0 0 0 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
WILSON 37 M ILLITRATE <2 ROYAPETTAH UM C 6 4 1 Y 34 B,C A N N N 5 0 20 0 0 0 0 0 0 0 0 0 0 0 0 4 5 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
NARAYANAN 52 M 9 >2 VILLIVAKKAM UM H 4 2 4 N 0 B WORK N N N 18 0 0 TB-F 0 0 0 0 0 0 ADS18 1.5 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4
THAMIZ 65 M 8 >2 PORUR M H 36 8 2 Y 26 B WORK N N N 6 0 40 SUICID 0 0 3 4 WORK 1 0 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
MURALI 42 M 5 >2 OTTERI UM H 12 6 2 N 0 BEETLENFELT GOO  N SMF N 18 0 0 0 TB-F 0 0 0 0 0 3 ADS15 1.5 0 4 5 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
ANANDPAL 36 M 6 <2 PULIANTHOPU M H 36 2 1 Y 34 B,C A N N N 1 0 10 0 TB-EB 0 1 4 A 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
RAJINI 42 M B.COM >2 KKNAGAR M H 3 4 1.5 Y 28 B,C A N DM N 0.5 0 15 0 0 0 1.5 6 A 10 0 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
GANESH 66 M 6 <2 MMDA M H 0 5 1 N 0 H POOR SUN DM,SHN 0 0 0 MI-F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 0
VINUTH 35 M 12 >2 MINT UM H 5 9 3 Y 26 B,H,M A N N N 0.75 0 8 PSYCHODM-M 0 1 1 A 3 0 0 0 0 0 0 0 0 4 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SHAHID 46 M 3 >2 TRIPLICANE M M 7 8 3 Y 28 B,C A N DM N 1 0 5 0 DM-M 0 3 1.5 A 15 0 0 0 0 0 0 0 4 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SAKTHI 26 M B.A >2 MYLAPORE UM H 2 3 1 N 6 B,C WORK N N N 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
PAKKIRI 54 M 4 <2 TAMBARAM M H 6 4.5 1 Y 40 B,C,H A N DM N 0.3 0 16 ADS-F TB-F 0 2 2 A 0 0 0 0 0 0 0 0 3 4 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
RAMARAO 55 M 2 <2 KODUNGAYOOR M H 10 12 2 Y 38 B,C,H A N DM,SHN 2 0 18 ADS-F,ETB-F 0 3 1 A 20 0 0 0 0 0 4 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
RANJANI 26 F 12 <2 EGMORE M H 0 6 2 N 0 N DINTKNON N N 0 0 0 ADS-F TB-F 0 2 1 WORK 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 5 0 0 0 0 0 0 0 0 0 0
SARAVANAN 38 M 9 >2 CHETPET M H 4 4 2 Y 36 B,H A N N N 3 0 10 ADS-F M-TB 0 3 3 A 45 0 0 0 0 0 0 0 0 4 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0
SATHISH 54 M 12 >2 VYSARPADI M H 12 9 3 Y 40 B,C A N N N 2 0 15 ADS-EBM-TB 0 5 3 A 20 0 0 0 0 0 4 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5
KAVIARASAN 44 M 5 <2 SAIDAPET M H 18 6 1 Y 40 B A N DM N 0.5 0 13 0 0 0 0 0 0 0 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
JOHN 36 M 4 >2 ROYPETTAH M C 6 11 1 Y 36 B A N N N 1 0 10 ADS-F TB-F 0 3 3 A 10 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
KUMAR 42 M 6 >2 SAIDAPET M H 12 3 3 Y 32 N A N SHT N 2 0 12 ADS-EBTB-M 0 4 4 A 30 0 0 0 0 0 4 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
KARTIK 53 M 2 >2 OTTERI M H 8 6 4 Y 34 B,C A N N N 0.5 0 10 ADS-YBDM-F 3 3 2 A 15 0 0 0 0 0 3 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
VETRI 44 M 3 >2 MMDA M H 24 8 3 Y 40 H A N N N 1.5 0 8 0 MI-M 0 0 0 0 0 0 0 0 0 0 4 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SELVAM 65 M 8 >2 KODUNGAYOOR M H 0 3 2 Y 28 N A N DM N 2 0 5 0 0 0 0 0 0 0 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SEKAR 24 M 9 <2 WASHERMENPET M H 3 2.5 0.5 Y 32 M A N N N 3 0 6 0 0 0 0 0 0 0 0 0 0 0 0 4 5 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
VIJAY 50 M B.COM >2 CHETPET M H 4 4 2 Y 36 B A N N N 1.5 0 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
MUTHU 56 M 4 >2 EGMORE M H 8 5 1 Y 34 N A N N N 2.5 0 8 ADS-EB0 0 0 0 0 0 1 0 0 0 0 4 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
KESAVAN 37 M 2 <2 KILPAUK UM H 6 4 1 Y 36 N A N N N 3 0 10 ADS-F 0 0 0 0 0 0 0 0 0 0 4 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
KRISHNAN 38 M 10 >2 ENNORE M H 3 8 3 Y 36 N A N C N 2 0 9 ADS-EBDM-ES 0 0 0 0 0 0 0 0 0 0 4 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
VISWAM 45 M 12 >2 TAMBARAM M H 26 12 4 Y 32 B,C A N N N 2.5 0 8 0 0 0 1 1 A 15 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
JAGAN 27 M 8 >2 KANNAGINAGAR UM H 8 15 4 Y 30 B,H A N N N 3 0 5 0 0 0 0 0 0 0 0 0 0 0 0 4 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
VINOTH 55 M 4 >2 MEENAMBAKKAM M H 12 8 3 Y 40 N A N CAD N 1.5 0 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SRINATH 47 M 9 <2 VILLIVAKKAM M H 4 6 3 Y 38 N A N N N 1 0 8 0 0 0 0 0 0 0 0 0 0 0 0 3 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
KAVIN 44 M 12 <2 KKNAGAR M H 6 9 4 Y 34 B,C,H,MA N N N 0.1 0 7 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
RAJU 38 M 12 >2 REDHILLS M H 8 10 3.5 N 0 N FELT GOOD N N 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0
SEKAR 45 M 7 >2 REDHILLS M H 10 7 3.5 N 0 N NAUSEA DEPREN N 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0
